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Summary 
 
The N-methyl-D-aspartate (NMDA) receptors belong to the family of ionotropic glutamate receptors. 
They play a critical role in neuronal pattern formation during development and in synaptic plasticity as 
molecular coincidence detectors. NMDA receptor is a tetrameric protein complex comprised of two 
obligatory NR1 subunits and two identical or different NR2 subunits, of which four types exist named 
NR2A-D. In rodents and other mammals, NR1 and NR2B are expressed in the entire central nervous 
system, already at embryonic stages, whereas NR2A expression starts and increases only postnatally to 
coexist with NR2B in the adult brain. Mice lacking the NR1 subunit or lacking the NR2B subunit die at 
birth, whereas mice lacking NR2A are viable. Both NR2A and NR2B containing NMDA receptors are 
implicated in synaptic plasticity, learning and memory formation but their distinctive functions are 
unknown. The NR2B subunit received a lot of attention because mice genetically altered to overexpress 
NR2B showed improved spatial reference memory and enhanced LTP. The lethality of the general 
NR2B knock-out gives rise to the necessity of a conditional knock-out, by which deleterious effects 
due to lack of NR2B during embryogenesis are prevented, and the physiological function of NR2B can 
be elucidated in the postnatal brain. For this purpose, a DNA construct for homologous recombination 
in embryonic stem (ES) cells was generated with NR2B allele exon 6 flanked by loxP sequences. This 
exon encodes the region preceding the first transmembrane domain of the NR2B subunit. As a 
selection marker, a neomycin resistance gene flanked by frt sites was introduced in intron 6. The 
selection marker was subsequently removed by flp recombinase from the targeted NR2B allele, and the 
ES cells were used for blastocyst injection to derive NR2B2lox mice. 
  
NR2B2lox mice were bred with TgCre4 mice, selectively expressing Cre recombinase in forebrain 
principal neurons, to generate mice heterozygous for the transgene TgCre4 and homozygous for the 
conditional NR2B allele (NR2B2lox/2lox). In these mice (NR2B∆Fb), postnatal forebrain principal neurons 
should lack NMDA receptors containing the NR2B subtype. Deletion of NR2B in NR2B∆Fb mice was 
revealed by electrophysiological measurements. In parallel, in this study, also lentiviral mediated gene 
delivery was used in vivo for Cre/loxP mediated DNA recombination. Recombinant lentivirus 
encoding Cre recombinase and the GFP protein under the control of the α-CaMKII promoter was 
delivered stereotactically to the hippocampal CA1 region of NR2B2lox/2lox mice at P20. Lack of NR2B 
was assessed by electrophysiological measurements of synaptic and whole-cell NMDA currents, using 
NR2B specific antagonists. Recordings from CA1 neurons revealed reduced NMDA currents, lack of 
sensitivity to ifenprodil, a selective blocker of NR2B containing NMDA receptors, and faster than wild 
type deactivation kinetics of NMDA mediated currents, indicating the effective loss of the NR2B-type 
NMDA receptors. Frequency and AMPA component of miniature EPSCs were unaltered whereas the 
NMDA component was reduced. Moreover an impairment of cellular LTP could be shown. Western 
blot analysis from hippocampal homogenates of NR2B∆Fb mice showed a ∼ 70% reduction of the NR2B 
subunit levels, and no significant change in the expression levels of NR2A, and of the AMPA receptor 
subunits GluR-A and GluR-B. Collectively, these studies describe a conditional mouse model for 
elucidating the particular physiological functions of the NR2B type of NMDA receptors in the adult 
forebrain.  
Zusammenfassung 
 
N-Methyl-D-Aspartat(NMDA)-Rezeptoren gehören zur Familie der ionotropen 
Glutamatrezeptoren. Sie spielen eine entscheidende Rolle bei der neuronalen Musterbildung 
während der Entwicklung sowie bei der synaptischen Plastizität als molekulare 
Koinzidenzdetektoren. NMDA-Rezeptoren sind tetramere Proteinkomlexe, die aus zwei 
obligatorischen NR1-Untereinheiten und zwei identischen oder verschiedenen NR2-
Untereinheiten, von denen es vier Typen (NR2A-D) gibt, gebildet werden. In Nagern und 
anderen Säugetieren werden NR1 und NR2B im gesamten zentralen Nervensystem bereits im 
Embryonalstadium exprimiert, die Expression von NR2A beginnt dagegen erst nach der 
Geburt und nimmt während der ersten postnatalen Wochen zu, so dass NR2B und NR2A im 
erwachsenen Hirn gemeinsam vorkommen. Mäuse, denen NR1 oder NR2B fehlen, sterben 
kurz nach der Geburt, während Mäuse ohne NR2A lebensfähig sind. Sowohl NR2A- als auch 
NR2B-enthaltende NMDA-Rezeptoren wirken mit bei synaptischer Plastizität, Lernen und 
Gedächtnisbildung. Die NR2B-Untereinheit erhielt starke Aufmerksamkeit, da Mäuse mit 
Überexpression von NR2B verbessertes räumliches Referenzzgedächtnis und Verstärkung 
von LTP zeigten. Die Letalität des generellen NR2B Knock-out erfordert einen konditionellen 
Knock-out, durch den die nachteiligen Effekte infolge des Fehlens von NR2B während der 
Embryogenese verhindert werden, und mit dem die physiologische Funktion von NR2B im 
postnatalen Gehirn aufgeklärt werden kann. Zu diesem Zweck wurde ein DNA-Konstrukt für 
die homologe Rekombination in embryonalen Stammzellen (ES-Zellen) hergestellt, in dem 
Exon 6 durch loxP-Sequenzen flankiert wird. Dieses Exon kodiert für die Region N-terminal 
vor der ersten Transmembrandomäne der NR2B-Untereinheit. Als Selektionsmarker wurde 
ein von frt-Sequenzen flankiertes Neomycin-Resistenzgen in Intron 6 eingeführt. Der 
Selektionsmarker wurde anschließend durch Flp-Rekombinase aus dem veränderten NR2B-
Allel entfernt und die ES-Zellen wurden in Blastozysten injiziert, um NR2B2lox Mäuse zu 
erhalten. 
 
NR2B2lox Mäuse wurden mit TgCre4-Mäusen verpaart, welche Cre-Recombinase 
ausschliesslich in Prinzipalzellen des Vorderhirns exprimieren, um NR2B∆Fb-Mäuse zu 
erhalten, die heterozygot für das Transgen TgCre4 und homozygot für das konditionelle NR2B-
Allel (NR2B2lox/2lox) sind. In NR2B∆Fb-Mäusen sollten postnatal in Prinzipalzellen des 
Vorderhirns NR2B-enthaltende NMDA-Rezeptoren fehlen. Die Deletion von NR2B in 
NR2B∆Fb-Mäusen wurde durch elektrophysiologische Messungen bestätigt. Parallel dazu 
wurden auch Versuche unternommen, bei denen in vivo lentiviral induzierte Cre-Expression 
für die DNA-Rekombination genutzt wurde. Rekombinante Lentiviren, die Cre-Recombinase 
und GFP unter der Kontrolle des α-CaMKII-Promoters exprimieren, wurden stereotaktisch in 
die hippocampale CA1-Region von homozygoten NR2B2lox/2lox Mäusen am Tag P20 injiziert. 
Das Fehlen von NR2B wurde durch elektrophysiologische Messungen von synaptischen und 
Ganzzell-Strömen untersucht, wobei NR2B-spezifische Antagonisten eingesetzt wurden. 
Messungen an CA1-Neuronen zeigten reduzierte NMDA-Ströme, das Fehlen von Ifenprodil-
Sensitivität sowie Deaktivierungskinetiken von NMDA-vermittelten Strömen, die schneller 
als in Wildtyp-Mäusen waren, alles Hinweise auf einen effektiven Ausfall von NMDA-
Rezeptoren vom NR2B-Typ. Frequenz und AMPA-Komponente von Miniatur-EPSC's 
blieben unverändert, die NMDA-Komponente war dagegen reduziert. Darüberhinaus konnte 
eine Verminderung des zellulären LTP gezeigt werden. Die Western-Blot Analyse von 
hippocampalen Homogenaten aus NR2B∆Fb-Mäusen ergab eine 70%ige Reduktion der NR2B-
Untereinheit und keine signifikante Änderung in der Expressionshöhe von NR2A sowie der 
AMPA-Rezeptoruntereinheiten  GluR-A und GluR-B. 
 
Zusammenfassend beschreiben diese Studien ein konditionelles Mausmodell, um die 
speziellen physiologischen Funktionen des NR2B-Typs der NMDA-Rezeptoren im 
erwachsenen Vorderhirn aufzuklären. 
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  Introduction 
1 INTRODUCTION  
 
1.1 Synaptic Transmission 
 
A synapse is the specialized junction where two neurons contact each other. It consists of 
the terminus of a presynaptic cell apposed to a postsynaptic cell. The process by which 
nerve cells signal one another at a synapse is termed as synaptic transmission. 
 
Based on the structure of apposition, synapses are categorised into two major groups: 
electrical and chemical. Electrical synapses occur at specialised sites called gap junctions, 
which physically connect the cytoplasm of the presynaptic and postsynaptic cells. 
Synaptic communication in the brain relies mainly on the chemical mechanisms. At 
chemical synapses, there is no structural continuity between pre- and postsynaptic 
neurons and the region separating the two cells is named as synaptic cleft. Presynaptic 
cells contain synaptic vesicles, which contain a neurotransmitter. Arrival of an action 
potential to the presynaptic axon terminal activates voltage gated calcium channels. The 
resulting transient elevation of the Ca2+ concentration causes vesicles to fuse with the 
presynaptic membrane, thereby releasing their neurotransmitter into the synaptic cleft. 
The neurotransmitter diffuses across the synaptic cleft and interacts with the ligand gated 
ionotropic or metabotropic receptors on the postsynaptic membrane. Ionotropic receptors 
are membrane proteins that form an ion channel. Upon binding the neurotransmitter the 
ionotropic receptor undergoes a confirmational change that results in the opening of the 
channel pore. On the other hand upon interaction with the neurotransmitter metabotropic 
receptors indirectly activate ion channels in the membrane through signal transduction 
mechanisms. While ionotropic receptors mediate fast synaptic activity in the range of 
milliseconds, metabotropic receptors mediate slower synaptic activity lasting seconds to 
minutes, often associated with changes in neuronal excitability and synaptic strength.  
 
Synaptic transmission in the CNS can be either excitatory or inhibitory. The main 
excitatory neurotransmitter is glutamate and main inhibitory neurotransmitters are GABA 
and Glycine. Glutamate activates ionotropic glutamate receptors as well as metabotropic 
glutamate receptors. These channels are permeable to Na+ and K+. Action of glutamate on 
 1
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ionotropic glutamate receptors is always excitatory whereas on metabotropic glutamate 
receptors it is either inhibitory or excitatory. GABA acts on ionotropic GABAA receptors 
and metabotropic GABAB receptors. GABAA receptors gate an intrinsic Cl- channel and 
GABAB receptors act on second messenger cascade often activates K+ channel. 
 
1.2 Ionotropic Glutamate Receptors 
 
Ionotropic glutamate receptors are ligand gated channels selectively permeable for Na+ 
and K+ and some of them also for Ca2+ ions, and they mediate the postsynaptic response 
at most of the excitatory synapses in the brain. Based on their preferential activation of 
specific agonists, they are subdivided in different subclasses: N-methyl-D-aspartate 
(NMDA) and non-NMDA ionotropic glutamate receptors (Dingledine et al., 1999). The 
non-NMDA receptors are comprised of the AMPA (α-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid) and the kainate receptor families. AMPA receptors are 
the fast excitatory neurotransmitter receptors in the CNS. They form hetero-oligomeric 
assemblies consisting of four different subunits termed GluR-A, GluR-B, GluR-C and 
GluR-D. Kainate receptors are formed by the subunits GluR-5, GluR-6, GluR-7, KA-1 
and KA-2 (Hollmann and Heinemann, 1994; Wisden and Seeburg, 1993). NMDA 
receptors consist of subunits termed NR1, NR2A, NR2B, NR2C, NR2D, NR3A. The 
different subunits of the AMPA, Kainate and NMDA receptors show amino acid 
identities higher than 60 per cent within the groups and less than 40 percent identity 
between the groups (Figure 1). They are mainly expressed in the CNS but there is 
evidence for the presence of subpopulations in pancreatic islet cells (Inagaki et al., 1995), 
osteoclasts and osteoblasts (Chenu et al., 1998), skin cells (Ault and Hindebrand, 1993) 
and cardiac ganglia (Gill et al., 1998). In addition, a fourth class of iGluR is represented 
by the δ1 and δ2 receptors that share 18-25% amino-acid identity with the other 
glutamate receptors subunits (Lomeli et al., 1993). These orphan subunits do not form 
functional channels by themselves, nor have they been shown to modify the function of 
other subunits. Zuo and co-workers showed their important role with the so called 
“Lurcher mice” which has a mutation in the δ2 receptor. These mice showed spontaneous 
degeneration of Purkinje cells and cerebellar ataxia (Zuo et al., 1997).  
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Figure 1: Phylogenetic diagram based on amino acid identities (Egebjerg and Jensen, 2002). 
 
1.2.1 Structure of the Ionotropic Glutamate Receptor Subunits 
 
All ionotropic glutamate receptors share the same transmembrane topology. Various 
approaches provide compelling evidence for a structure that consists of an extracellular 
N-terminus, an intracellular C-terminus, and an extracellular loop between M3 and M4. 
Thus, only three regions (M1, M3, and M4) completely span the membrane, while the 
channel lining domain is formed by a cytoplasm facing re-entrant loop M2. The N-
terminal domain controls proper assembly of receptor complexes (Ayalon and Stern, 
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2001). Targeting of the receptor to the synapse and its localization depend on series of 
interactions with other proteins. The C-terminal domain influences receptor function and 
proper receptor localisation by its interaction with trafficking, motor, signalling and 
scaffolding proteins (Barry and Ziff, 2002). The M2 domain contains the critical Q/R/N 
site, and this controls the key permeation properties of the channel. The bipartite ligand 
binding domain is formed by the two segments within the N-terminal domain (S1) and 
the extracellular loop between membrane segments M3 and M4 (S2) (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Transmembrane topology of ionotropic glutamate receptors 
Three transmemnbrane domains (M1, M3, M4) span the membrane. The pore lining region is generated by 
M2, which enters the membrane from the intracellular surface forming a pore loop structure. The Q/R/N 
site is in the pore lining region. The alternatively spliced flip/flop exon exists in AMPA receptors and is 
located extracellularly. S1 and S2 designate the two parts of the ligand binding domain (Cull-Candy, 2002). 
 
1.2.2 The Q/R/N Site of the Ionotropic Glutamate Receptors  
 
The cation selectivity of the NMDA and non-NMDA receptors depends on a critical 
residue in the pore-lining region. In this region, NMDA receptor subunits contain an  
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asparagine (N) at a position homologous to the Q/R (glutamine/arginine) site of the 
AMPA and kainate receptor subunits. Therefore this site is collectively referred as the 
Q/R/N site. High Ca2+ permeability and voltage dependent blockade of NMDA receptors 
are critically dependent on the presence of asparagine at this site. Although both NR1 and 
NR2 subunits contribute to the permeation pathway, they do not contribute equally to the 
selectivity filter. Thus swapping asparagine for glutamine (N → Q) in NR1 affects the 
Ca2+ permeability of the channel but not its Mg2+ block. The same substitution in TM2 
region of the NR2 subunits affects the Mg2+ block, but not the Ca2+ permeability 
(Burnashev et al., 1992; Cull-Candy, 2002). The amino acid occupying the Q/R site of 
the AMPA receptor subunits is controlled by RNA editing and determines the 
conductance, rectification and divalent cation permeability of the ion channel (Sommer et 
al.,1991; Verdoorn et al., 1991). The presence of an arginine residue at this position in 
GluR-B renders AMPAR channels impermeable to Ca2+, whereas a glutamine at this 
position in GluR-A, -C and -D produces Ca2+ permeable channels.  
 
1.3 NMDA Receptors 
 
1.3.1 NMDA Receptor Subunits and Splice Variants 
 
The NMDA subtype of the glutamate receptor channel plays an important role in synaptic 
plasticity as a molecular coincidence detector and in neuronal pattern formation during 
development (Dingledine et al., 1999). It has also also been implicated in various disease 
states such as epilepsy and neurodegeneration following ischemia. Three families of 
NMDA receptor subunits have been identified: the ubiquitously expressed NR1 subunit, 
(four distinct NR2 subunits (A, B, C and D), and two NR3 subunits (A, B) (Moriyoshi et 
al., 1991; Sugihara et al., 1992; Monyer et al., 1992,1994; Das et al., 1998; Hollmann et 
al., 1999). The NR1 subunit has up to eight functional isoforms arising from a single gene 
due to alternative splicing at three independent sites (Dingledine et al., 1999). Similar to 
NR1 subunit, NR2 and NR3 subunits (apart from NR2A) has several splice variants 
although the functional relevance of the different splice variants remains unclear. NMDA 
receptors are formed as heteromers containing two obligatory NR1 and two NR2 subunits 
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(Seeburg et al., 1993; Laube et al., 1998; Kuryatov et al., 1998). In the tetrameric receptor 
complex, identical subunits sit adjacent to each other (Behe et al., 1995; Laube et al., 
1998; Schorge and Colquhoun, 2003). Glycine as a co-agonist potentiates the NMDA 
response by augmenting the NMDA receptor-channel opening frequency and, thus, it 
increases the open state probability of the channel. While NR2 subunits contain the 
binding site for glutamate, NR1 carries the binding site for glycine. NR3 subunits co-
assemble with NR1 to form excitatory glycine gated receptor channels that are unaffected 
by glutamate or NMDA (Chatterton et al., 2002). Neurons contain a large pool of NR1, 
which is unassembled with NR2, and does not reach the cell surface, but is retained in the 
endoplasmic reticulum (ER) and rapidly degraded (Chazot and Stephenson, 1997a; Huh 
and Wenthold, 1999). The retention appears to be dependent on a signal in the C terminal 
domain. It has been suggested that assembly of NR1 with NR2 subunits results in the 
masking of the retention signal and, therefore, leads to targeting to the membrane (Barria 
and Malinow, 2002).  
 
1.3.2 Functional Features of NMDA Receptors 
 
1.3.2.1 NMDA Receptors as “Coincidence Detectors“ During Synaptic Transmission 
 
For many central synapses, the transmitter activates a mixed population of non-NMDARs 
and NMDARs. AMPA receptors mediate fast synaptic currents while NMDA receptors 
mediate currents that are slower and longer lasting. During synaptic transmission, the 
rates at which the responses of NMDA receptors rise and decline upon application and 
removal of agonists are markedly slower than those of non-NMDA receptors (Forsythe et 
al., 1988; Vicini et al., 1998). NMDA receptors first open about 10 ms after glutamate is 
released into the synaptic cleft and continue to open and close for hundreds of 
milliseconds until glutamate unbinds from the receptor (Dzubay et al., 1996; Behe et al., 
1999). It is the slow deactivation rate of NMDA receptors that governs the duration of the 
excitatory postsynaptic potential which is a measure of the strength of synaptic signalling 
(Lester et al., 1990).  
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NMDARs form cation-selective channels with a high permeability to Ca2+ as well as Na+ 
and K+ (MacDermott et al., 1986; Jahr and Stevens, 1993). Moreover, they are blocked in 
a voltage dependent manner by binding of a Mg2+ ion to a site within the pore (Nowak et 
al., 1984; Mayer et al., 1984). The gating of NMDARs is therefore controlled by a 
combination of ligand(s) and voltage, making them distinct from other types of ligand-
gated receptors. High Ca2+ permeability and voltage dependent blockade by extracellular 
Mg2+ are considered to be important for the function of receptors in mediating long term 
changes in synaptic efficacy and cytotoxic effects of glutamate in hypoxic conditions.  
 
Na+ Ca2+
Mg2+ site 
Extracellular 
side  
Cytoplasmic 
side 
Zn2+ site 
K+
Glycine site 
Glutamate 
recognition site
Polyamine site
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3: Schematic representation of the NMDA receptor complex. 
The NMDA receptor complex possesses a glutamate recognition site to which receptor agonists and 
competitive antagonists bind, as well as binding sites for glycine, polyamines, and the ions Mg2+ and Zn2+. 
Channel opening permits an influx of Na+ and Ca2+ ions and an efflux of K+ ions (After Scatton, 1993). 
 
This voltage-dependent block by Mg2+ is relieved as the postsynaptic cell is depolarised, 
allowing the NMDAR to function as a coincidence detector of pre- and postsynaptic 
activity. Thus, the postsynaptic receptor permits an influx of Ca2+ and Na2+ ions only at 
those synapses that receive high frequency presynaptic activity (Bourne and Nicoll, 
1993). As a result, opening of NMDA receptors leads to an influx of cations including 
 7
  Introduction 
Ca2+ and the permeation of Ca2+ through NMDA receptor ion channels initiates signal 
transduction cascades that in turn modulate synaptic strength (MacDermott et al., 1986).  
 
1.3.2.2 Gating and Pharmacological Properties of NMDA Receptors 
 
As mentioned above, NMDA receptor channels show high permeability to Ca2+ ions 
which, unlike the Ca2+ permeability of AMPARs, is independent of the subunit 
composition. The residue at the N/Q/R site of the NR1 subunit is the main determinant of 
the Ca2+ permeability of NMDARs.  
 
Figure 4: Sub
A clear diffe
extracellular M
NR1-NR2A an
(Monyer et al.
 
The extent o
There is a c
   
unit-specific Mg2+ block of recombinant NMDA receptors  
rence in the strength of the voltage-dependent block of glutamate induced currents by 
g2+ is observed for different NR1-NR2 channel subtypes. In the presence of 1 mM Mg2+ 
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induced currents by extracellular Mg2+ for different NR1-NR2 channel subtypes (Figure 
4). In a heterologous expression system, it has been demonstrated that in physiological 
concentrations of 1 mM extracellular Mg2+, the NR1-NR2A and NR1-NR2B channels are 
characterized by stronger voltage sensitivity to Mg2+ block than the NR1-NR2C and 
NR1-NR2D channels (Monyer et al., 1994).  
 
Furthermore, the decay of NMDAR mediating excitatory postsynaptic currents (EPSCs) 
and the apparent affinity of the receptor for glutamate are both strongly influenced by the 
identity of the NR2 subunits involved. NR2A-containing receptor channels differ from 
the other channel subtypes by considerably shorter offset decay time courses after a brief 
application of L-glutamate, which is thought to be crucial for the coincidence detection of 
the pre- and postsynaptic activities. NMDA receptor subtypes differ in their 
pharmacology. D-AP5 is perhaps the most commonly used NMDA receptor antagonist, 
which shows a selectivity for NR2A and NR2B containing NMDA receptor complexes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Subunit-specific offset decay time constants of recombinant NMDA receptors.  
 
 
MK-801 is the NMDA receptor open channel blocker, which acts by binding to the open 
pore of the NMDA receptor channel. Thus it is a non-competitive antagonist. Ifenprodil 
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and Ro 25-6981 are the polyamine site antagonists of the NMDARs whose effects are 
specific for channels containing the NR2B subunit. Furthermore NVP-AAM077 
preferentially blocks NR2A containing receptors (9 fold preferance for NR2A compared 
to NR2B containing receptors) (Paoletti et al., 2006). Thus, the presence of different NR2 
subunits confers distinct gating and pharmacological properties to heteromeric NMDARs. 
 
Different NR2 subunits confer different properties to the NMDAR channel. The NR2A 
subunit has faster deactivation time and increased desensitisation in contrary to the NR2B 
subunit (Monyer et al., 1994). 
 
1.3.3 Developmental Expression Profile of NMDA Receptors 
 
One indication of the functional importance of NMDAR subunit diversity comes from 
different regional and developmental expression profiles of the subunits. The NR1 
subunit displays ubiquitous expression in all the brain regions and at all stages of 
development, in keeping with the view that NR1 is indispensable in the formation of 
functional NMDARs. NR1 subunit mRNA appears as early as E14, peaks around P20, 
and subsequently declines to adult levels. The expression of the NR1 splice variants, 
however, shows considerable regional and developmental heterogeneity. In contrast to 
the NR1 subunit, mRNA for NR2A, NR2B, NR2C and NR2D subunits are differentially 
distributed. Furthermore, in situ hybridisation studies (Monyer et al., 1994), and 
immunoprecipitation experiments (Sheng et al., 1994) have demonstrated that their 
expression is developmentally regulated. 
 
The expression of NR2B and NR2D begins at least as early as E14, whereas NR2A and 
NR2C are first detected perinatally. At embryonic stages, NR2B mRNA is expressed in 
the entire brain whereas NR2D mRNA is expressed in the diencephalon and brainstem. 
After birth, NR2A mRNA appears in the entire brain whereas NR2C mRNA is seen 
mainly in the cerebellum. The expression of NR2B mRNA becomes restricted to the 
forebrain where that of NR2D mRNA is strongly reduced (Figure 5). 
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ll NR2 transcripts reach peak around P20-P25 except for NR2D, which peaks around 
7 and subsequently declines to adult levels. In pyramidal neurons of the neocortex and 
he hippocampus, NR2B is coexpressed with NR2A; in granule cells of the  
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cerebellum NR2B is replaced by NR2A and NR2C at about P12 (Figure 6). In the adult 
CNS, NR2A and NR2B are the major subunits expressed in the neocortex and the 
hippocampus. 
 
1.3.4 Effect of the Subunit Expression Profile on Kinetic Properties 
 
The gradual increase of the NR2A subunit expression in the constant presence of the 
NR2B subunit results in different kinetic properties of NMDA receptors. It appears that 
during development, increasing the contribution of NR2A-containing receptors to the 
synaptic current decreases the contribution from the NR2B subunit. Functional 
consequence of altering the NR2A/NR2B ratio is a change in the kinetics of EPSCs 
mediated by NMDARs. In vitro NR2A containing NMDARs have shorter current 
durations than receptors containing the NR2B subunit (Monyer et al., 1994). Also during 
postnatal development, the duration of currents mediated by NMDA receptors decreases 
and it has been shown that regardless of the postnatal age, cells expressing NR2A subunit 
mRNA had faster NMDAR EPSCs than cells with no expression of this subunit (Figure 
6) (Flint et al., 1997). The proportion of cells expressing NR2A and displaying fast 
NMDAR EPSCs increases during postnatal development and, thus, provide a molecular 
basis for the developmental changes in EPSCs. Furthermore, an appealing hypothesis 
suggested that an activity-dependent switch in the subunit composition of NMDARs 
accounts for the shortening of NMDAR currents in visual cortex during development 
(Philpot et al., 2001). NR2A subunits are incorporated synaptically late in development, 
whereas NR2B subunits are still highly persistent at extrasynaptic sites (Stocca and 
Vicini, 1998; Rumbaugh and Vicini, 1999; Tovar and Westbrook, 1999). Moreover, some 
native NMDAR channels contain more than one type of the NR2 subunit in the same 
assembly (Dunah et al., 1998; Sheng et al., 1994; Luo et al., 1997). Although studies in a 
heterologous system suggest the formation of functional triheteromeric assemblies of 
NR1/NR2A/NR2B (Vicini et al., 1998; Tovar and Westbrook, 1999), it is still unknown 
to what extent these assemblies are formed in vivo. 
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Figure 6: The developmental changes in EPSCs during postnatal development. 
Duration of NMDAR EPSCs decreases during postnatal development in somatosensory cortex. The 
averaged EPSCs from P4 and P9 neurons show a significant difference in the decay time constant (Flint et 
al., 1997). 
 
1.3.5 Importance of the NR2A and NR2B Subunits for Learning and Memory 
 
According to Hebb´s rule, learning and memory are represented by a change in synaptic 
strength between two neurons being active at the same time (Hebb et al., 1949). Changes 
in synaptic strength are referred by the concept of synaptic plasticity. At the molecular 
level, the synaptic strengthening occurs by a complex process that is initiated by the 
action of NMDA receptors. In this regard, NMDA receptors play a role as coincidence 
detectors (Bourne and Nicoll, 1993) since they only open when the neurotransmitter is 
bound and the postsynaptic membrane is depolarised to a certain extent. This implies that 
enhanced synaptic coincidence detection would lead to better learning and memory. 
Understanding how memory works is, by general agreement, one of neurobiology`s 
central problems. Naturally, many neurobiologists are concerned how synaptic strength is 
regulated to store information; that is, they are interested in synaptic plasticity. At 
synaptic levels, it has been proposed that long term potentiation (LTP) and long term 
depression (LTD) are the key synaptic mechanisms for cortical plasticity (Bliss and 
Collingridge, 1993; Linden et al., 1994; Lishman et al.,1994; Nicoll and Malenka, 1995; 
Malenka and Bear, 2004). 
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“Hippocampus” is the latin word for “sea horse”, and early anatomists gave this name to 
a part of the brain that is shaped somehow like a sea horse. The hippocampus has been 
identified as brain region concerned with encoding declarative and spatial memories and 
is therefore typically, but not exclusively, used to study LTP/LTD. Long term 
potentiation of synaptic transmission in the hippocampus is the primary experimental 
model for investigating the synaptic basis of learning and memory in vertebrates. Both 
LTP and LTD in hippocampus require the NMDAR activation (with the exception of 
mossy fiber-CA3 synapses).  
 
The trigger for both LTP and LTD is Ca2+ influx through NMDA receptors. It is believed 
that the quantity of Ca2+ that enters the cell determines the induction of LTP or LTD: 
little calcium produces LTD and a lot of calcium produces LTP. In synapses displaying 
LTP, a brief high-frequency burst of synaptic activity leads to an immediate and enduring 
increase in synaptic efficiency (Bliss and Collingridge 1993). 
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igure 7: By stimulating a particular pathway (the Schaffer collaterals comprised of axons from pyramidal 
ells in a region of hippocampus known as CA3) and recording from any of the pyramidal cells in the 
ippocampal region designated CA1, the electrophysiologist can study direct (monosynaptic) excitatory 
ynaptic connections (Stevens and Sullivan, 1998). 
ong term depression as the inverse of LTP is a long lasting reduction in synaptic 
ransmission. In contrast to LTP, more prolonged synaptic activity at a lower frequency 
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gives rise to LTD. In both cases antagonists of the NMDA receptors block induction of 
the long-lasting change (Bliss and Collingridge 1993; Dudek and Bear, 1992; Mulkey 
and Malenka, 1992; Bliss and Schoepfer, 2004). 
 
A sufficient rise in Ca2+ within the dendritic spine activa
triggers LTP. Several protein kinases have been implicate
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1.3.6. Characterisation of the Functional Role of NR2B 
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overexpression of the NR2B transgene alters NMDAR function and synaptic plasticity in 
hippocampus and insular cortex (Tang et al., 1999; Wei et al., 2001), it does not alter 
NMDAR function or synaptic plasticity in visual cortex. Yet, in another study using 
hippocampal neuronal cultures it has been shown that the increased expression of the 
NR2B subunit does not increase the number of NR2B receptors in the synapse (Barria 
and Malinow, 2002). 
 
In the “smart mouse” model, overexpression of the NR2B subunit in the forebrain of 
transgenic mice leads to enhanced activation of NMDA receptors, facilitating synaptic 
potentiation in response to stimulation at 10-100 Hz. These mice exhibit superior ability 
in learning and memory in various behavioural tasks, showing that NR2B is critical in 
gating the age-dependent threshold for plasticity and memory formation. NMDA-receptor 
dependent modifications of synaptic efficacy, therefore, represent a unifying mechanism 
for associative learning and memory. Consequently, it has been proposed that the genetic 
enhancement of mental and cognitive attributes such as intelligence and memory in 
mammals is feasible. However, the authors did not try to prove that the mentioned effects 
of the transgenic overexpression of NR2B are not simply due to the higher number of 
NMDA receptors. A possible control would have been transgenic overexpression of 
NR2A. In an other study a transgenic mice with the overexpression of the KIF17 (kinesin 
superfamily protein 17) in forebrain was generated (Wong et al., 2002). In vitro KIF17 
was shown to be responsible for the transport of NR2B in neurons (Guillaud et al., 2003). 
In mice overexpressing KIF17, NR2B subunit expression was upregulated. In accordance 
with the previous results from the smart mouse, these mice also showed superior ability 
in learning related behavioural tests (Wong et al., 2002). Additionally, in an NR2B 
knock-down model of aged rats, NR2B anti-sense treatment abolished LTP and impaired 
spatial learning in behaviour tasks (Clayton et al., 2002). Inconsistent with the previous 
studies, it has been shown that in adult animals NR2A dependent signalling dominates 
and activation of NR2A is sufficient to induce LTP, and contribution of the NR2B 
subunit is redundant (Köhr et al., 2003).  
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1.3.7 Knock-out Mice and Mice with C-terminally Truncated Receptor Subunits 
 
For each of the known NMDA receptor subunits a knock-out mouse has been generated 
(Forrest et al., 1994; Li et al., 1994; Ikeda et al., 1995; Sakimura et al., 1995; Ebralidze et 
al., 1996; Kutsuwada et al., 1996; Das et al., 1998). The absence of NMDARs in NR1 
knock-out mice appears to lead to perinatal death (Forrest et al., 1994; Li et al., 1994), 
which is an indication of important functions for NMDARs in brain physiology. NR2A 
knock-out mice showed impaired hippocampal plasticity (Sakimura et al., 1995). In these 
mice no morphological or anatomical abnormalities are observed. However, there is a 
significant decrease of the current mediated by the NMDA receptors and only little LTP. 
They show moderate behavioural deficits in some learning tasks (Sakimura et al., 1995; 
Kiyama et al., 1998). Mice lacking a functional NR2B gene die at birth (Kutsuwada et al., 
1996). NR2B knock-out mice which were rescued by hand feeding fail to form the 
whisker-related neural pattern (barrelets) in the brain stem trigeminal complex and show 
impaired synaptic plasticity in the hippocampus. Perinatal lethality was found for NR2B 
knock-out but not for NR2D knock-out mice (Ikeda et al., 1995), indicating that during 
CNS development, the NR2B subtype is the more important of the two. 
 
In addition to the above mentioned knock-out models, several different gene-targeted 
mouse lines expressing C-terminally truncated NR2 subunits have been generated 
(Sprengel et al., 1998; Mori et al., 1998). NMDARs possess extended intracellular C-
terminal domains by which they interact with diverse proteins of the postsynaptic density 
(PSD) for purposes of synaptic localisation, clustering, and signal transduction (Sheng, 
1996; Kennedy, 1997, 1998; Kornau et al., 1997; Kim and Huganir, 1999). The C-
terminal domains of NR2A and NR2B are potential targets for tyrosine kinases, CaM 
kinase II, and protein kinases A and C (Moon et al., 1994; Wang and Salter; 1994, Köhr 
and Seeburg, 1996; Omkumar et al., 1996; Leonard and Hell, 1997; Tingley et al., 1997). 
The carboxy terminal domains of all four NR2 subunits are large compared to those of 
other ionotropic glutamate receptors. Thus, the C-terminal domain of NR2A subunit has 
627 amino acids, of NR2B subunit has 645, in comparison, the NR1-1 subunit has only 
105 amino acids. The regulation of NMDA receptor activity can be caused by direct 
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phosphorylation of the receptor protein or may involve the phosphorylation of associated 
postsynaptic proteins (Zheng et al., 1999). Mice expressing C-terminally truncated NR2B 
subunits die perinatally (Mori et al., 1998; Sprengel et al., 1998), whereas mice 
expressing C-terminally truncated NR2A subunits show impaired synaptic plasticity and 
contextual memory (Sprengel et al., 1998). Notably, it has been suggested that C-terminal 
signalling events are also critical for LTP induction (Köhr et al., 2003). Moreover, in the 
analysis of mice with truncation of the C-terminal domain an apparent reduction of the 
truncated NR2A at synaptic sites was seen, which could be due to the impaired targeting, 
transport or anchoring. Therefore it was proposed that the C-termini of NR2A subunits 
are necessary for NMDA receptor channels to achieve appropriate densities near release 
sites (Steigerwald et al., 2000). In mutant mice expressing the truncated NR2B subunit, 
the effect on synaptic function was examined at hippocampal CA1 synapses during 
neonatal stages. It has been shown that NMDA receptor mediated excitatory postsynaptic 
potentials (EPSPs) in the hippocampal CA1 region were strongly reduced in those mice, 
although the expression level of the truncated protein was comparable to that of the 
NR2B protein in wild-type mice (Mori et al., 1998). Furthermore, it has been suggested 
that the carboxy-terminal truncation of the NR2B subunit has little effect on the 
expression of the subunit protein but does affect its efficient clustering and synaptic 
localization (Mori et al., 1998). Mice in which the C-terminal domains of the NMDA 
receptor subunits are truncated show the same severe phenotype as the above mentioned 
corresponding knock-out mice. Thus, both genetic paradigms independently lead to the 
functional ablation of NMDAR subunits. Neither with the above mentioned experimental 
models nor with the knock-out mice and mice with the C-terminal truncation, could the 
physiological significance of the NR2B subunit in adult mice be clearly characterised. 
 
1.3.8 Pharmacological Approaches to Study the Contribution of NR2A and NR2B 
Subunits to Synaptic Plasticity 
 
Recent studies using pharmacological blockade of NMDAR subtypes proposed that 
NR2A-containing receptors are involved in LTP induction, whereas NR2B-containing 
receptors are involved in LTD induction in the hippocampus and perirhinal cortex (Liu et 
al., 2004; Massey et al., 2004). Liu and co-workers used two NR2B specific antagonists 
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(Ifenprodil and Ro25-6981) together with a recently developed NR2A antagonist (NVP-
AAM077) to dissect subunit involvement in LTP and LTD at synapses on pyramidal cells 
in area CA1 of the hippocampus. Both forms of synaptic plasticity can be blocked by the 
NMDA receptor antagonist D-AP5. The new and unexpected result is that LTP is 
mediated by NMDA receptors containing NR2A subunits, whereas LTD requires 
activation of receptors containing NR2B subunits. This finding suggests that the NR2B 
receptors in the hippocampus may not contribute to learning-related synaptic potentiation, 
however, no behavioural study has demonstrated the inhibitory effect that NR2B 
antagonists may have on learning when injected locally in the hippocampus. This result is 
at odds with the previous findings of Tang and co-workers which showed the important 
contribution made by NR2B subunits to hippocampal LTP, but not to LTD. In contrast to 
the conclusions of Liu and co-workers, using a similar pharmacological approach another 
study demonstrated that LTP induction at CA3 to CA1 synapses with different induction 
protocols does not require a particular NMDAR subtype (Berberich et al., 2005). It has 
been proposed that LTP can be induced by tetanic stimulation in the presence of 400 nM 
NVP via NR2B-type NMDARs, which was not observed by the previously mentioned 
study. In addition, they showed that LTP induction by repeated tetanic stimulation was 
not prevented by the NR2A and NR2B specific antagonists. Thus, NR2B-type NMDARs 
induce LTP when NR2A-type signalling is genetically (Kiyama et al., 1998; Köhr et al., 
2003) or pharmacologically impaired. The authors argue that it is not the NMDAR 
subtype, which determines the polarity of synaptic plasticity. They proposed that it is the 
pattern of synaptic activation, by triggering different signalling cascades, which directs 
the response of synaptic plasticity. This view has been challenged by another study (in 
hippocampal neuronal cell cultures) suggesting that NR2B-containing receptors play a 
crucial role in synaptic plasticity by recruiting CaMKII to the synapse, a key component 
of the underlying signalling transduction pathway (Barria and Malinow 2005). 
Furthermore, it has been suggested that both NR2A and NR2B subunits are critical for 
the induction of LTD and LTP in anterior cingulate cortex (ACC) (Toyoda et al., 2005; 
Zhao et al., 2005). Likewise, activation of NR2B in the ACC is important for the 
acquisition of contextual fear memory, which is consistent with the enhancement of 
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contextual fear memory in transgenic mice over-expressing NR2B in forebrain (Tang et 
al., 1999). 
 
1.3.9 NMDA Receptors and Disease 
 
Ca2+ influx via NMDAR channels is known to be essential for triggering synaptic 
plasticity, but excessive calcium influx through NMDA receptors can cause excitotoxic 
neuronal death. Therefore blockade of NMDARs is neuroprotective in animal models of 
both stroke and seizure (Lee et al., 1999) and, consequently, NMDA receptors have 
become a primary focus of excitotoxic research. Excitotoxicity is a critical mechanism 
contributing to neurodegeneration during ischemia or hypoxia. Major events in the 
cascade triggered by hypoxia or ischemia include over-stimulation of NMDA receptors, 
Ca2+ entry into cells, activation of Ca2+-sensitive enzymes such as nNOS (neuronal nitric 
oxide synthase), production of oxygen free radicals, mitochondrial impairment, and 
subsequent necrosis and apoptosis. Studies indicate that synaptic and extrasynaptic 
receptor pools have different subunit compositions and form distinct receptor 
populations: NR2A containing NMDA receptors are predominantly localised at synaptic 
sites, whereas NR2B containing NMDA receptors are mainly at extrasynaptic sites 
(Tovar and Westbrook, 1999). It has been proposed that Ca2+ entry through the 
extrasynaptic NR2B containing NMDA receptors are responsible for neuronal cell death 
(Hardingham et al., 2002). However, inconsistent with this conclusion, a recent study of 
Coserea (Coserea Dissertation, 2005) shows that both NR2A and NR2B subunits are 
playing a critical role in excitotoxic neuronal death. 
 
Inappropriate activation of NMDA-receptors is also causally involved in progressive 
neurodegenerative diseases such as Alzheimer´s disease (AD), Huntington`s disease 
(HD) and Parkinson´s disease. In animals, overactivation of the NMDA receptors in 
neostriatum most closely reproduces the neuropathological, neurochemical, and 
behavioural changes of HD. As well, postmortem analysis of brain tissue from patients 
with HD suggests that neurons with high expression of NMDA receptors are particularly 
vulnerable to degeneration (Chen et al., 1999). Selective antagonism of the NR2B subunit 
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has been shown to improve the treatment of Parkinson`s disease. CP-101,606 has direct 
antiparkinsonian actions in rodents and monkeys, and it synergistically potentiates the 
motoric improvements accompanying L-Dopa treatment (Steece and Collier 2000). Some 
results suggest that NMDA receptor subunits are selectively and differentially reduced in 
brain areas of AD patients. Modest decrease in the NMDA receptor subunits NR1, NR2A 
and NR2B was found in the hippocampus and frontal cortex (Loftis et al., 2003).  
 
Some studies suggest that hypofunction of NMDA receptors induced by various NMDA 
receptor antagonists precipitates a transient psychotic state (a positive symptom of 
schizophrenia) in healthy individuals (Gao et al., 2000). Mice with reduced NR1 subunit 
expression (5% of normal levels) (Mohn et al., 1999) or NR2A subunit deletion 
(Miyamoto et al., 2001) show symptoms related to schizophrenia. The NR2B subunit is 
also implicated in pain perception. Different from the previously described cognitive 
enhancement, mice over-expressing the NR2B subunit in the forebrain demonstrate a 
selective enhancement of persistent pain and allodynia (Wei et al., 2001). This has led to 
the suggestion that NR2B-selective antagonists may be useful in the treatment of chronic 
pain. 
 
It is believed that the NR2A and NR2B subunits play important roles in synaptic 
plasticity, learning and memory. However, none of the investigations using transgenic 
models, knock-out mice, mice with the C-terminal truncation or pharmacological studies 
give a definitive explanation and characterisation of the physiological significance of the 
NR2B subunit in adult mice. Further investigation and characterisation of the functional 
importance call for a conditional knock-out of the NR2B gene. 
 
2.1 Conditonal Knock-out of the NR2B Gene Using the Cre/loxP System 
 
The knock-out technology (Capecchi et al., 1989) is instrumental for the understanding of 
the physiological function of a gene. The technique is also named reverse genetics and 
differs from the traditional forward genetics technique in which random mutations are 
introduced to screen a high number of organisms in an effort to search for a certain 
phenotype. The function of a gene can be indirectly explained from the phenotype of the 
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corresponding knock-out mouse. A method to study the consequence of a deletion of an 
important gene is to use behavioural tests. Although this approach to gene inactivation is 
valuable, for many applications it is important that the inactivation of a particular gene 
occurs in a conditional manner such as in a predefined cell lineage or at a certain stage of 
development. Such conditional gene targeting would not only overcome problems posed 
by the fact that a null mutation in germ line is often lethal, but would also allow a more 
precise analysis of the impact of a mutation on individual cell lineages. Strategies 
exploiting site specific DNA recombination have been incorporated into transgenic and 
gene targeting procedures to allow in vivo manipulation of DNA in embryonic stem (ES) 
cells (Gu et al., 1993; Orban et al., 1992) or living animals (Lakso et al., 1992; Gu et al., 
1994). A large number of site-specific DNA recombinases have been described from 
bacteria and yeast, and the recombination reactions that they catalyse span a wide range 
of complexity (Kilby et al., 1993). In conjunction with inducible systems for controlling 
Cre expression and function, these recombination based strategies are likely to have a 
profound impact on developmental biology and generation of useful animal models of 
human disease (Sauer et al., 1998)  
 
Cre recombinase from bacteriophage P1 (Sternberg et al., 1981) and Flp recombinase 
from Saccharomyces cerevisiae are the two members of the integrase family of site 
specific recombinases (Lewandoski et al., 2001). They are used to conditionally control 
gene expression by site specific DNA recombination. Cre and Flp recombinases catalyse 
a conservative DNA recombination (a DNA recombination reaction in which there is no 
net change in base pairs between the products and the reactants) between 34-bp 
recognition sites (loxP and FRT). This system allows researchers to create a variety of 
genetically modified animals and plants with the gene of their choice being externally 
regulated (Kuhn, et al., 2002; Ghosh, et al., 2002). With the recombinase activity, null 
alleles could be generated in a tissue-specific and developmentally regulated manner. 
(Orban et al., 1992). The Cre/loxP system is the most frequently used owing to historical 
contingency, as it was the first well-developed recombination system. The general 
strategies are the same for the Flp/Frt system (Lewandoski et al., 2001). The structural 
biochemistry of the Cre/loxP system showed that Cre is the 38 kDA product of the cre 
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(cyclization recombination) gene of bactreriophage P1. Its role in the P1 life cycle is 
believed to include cyclisation of the linear genome following infection of the host cell 
and resolution of P1 dimers generated by homologous recombination to promote stable 
segregation of the P1 chromosome to daughter cells (Sternberg et al., 1981). Cre 
recognises a 34 bp site on the P1 genome called loxP (locus of X-over of P1) and 
efficiently catalyses reciprocal conservative DNA recombination between pairs of loxP 
sites. The loxP sites consist of two 13-bp inverted repeats flanking an asymmetric 8-bp 
spacer region. One molecule of Cre binds per inverted repeat; or two Cre molecules line 
up at one loxP site. The recombination occurs in the spacer region that gives the loxP site 
an overall directionality (Sauer and Henderson, 1988). In Cre mediated recombination, 
resultant DNA structures are dependent upon the orientation of loxP sites. Direct repeats 
of loxP dictate an excision of intervening sequences leaving one loxP site behind whereas 
inverted repeats specify inversion. This precise removal of DNA can be used to eliminate 
an endogenous gene or transgene and to activate a transgene.  
 
   ATAACTTCGTATA  ATGTATGC  TATACGAAGTTAT 
 
           inverted repeat             spacer    inverted repeat 
 
Figure 8: The loxP site contains two 13 bp inverted repeats and the asymmetric 8 bp spacer 
region. 
 
To obtain the conditional (meaning tissue and time specific) knock-out, two mouse lines 
are required. The first line is a conventional transgenic line in which expression of Cre 
recombinase is driven by a tissue-specific or cell type-specific transcriptional promoter. 
The second line embodies a target gene to be silenced flanked by two loxP sites (floxed 
gene) in the same orientation. In offspring derived from intercross between these lines, 
Cre/loxP site dependent recombination (excision and consequently inactivation of the 
floxed gene) will occur in cells expressing Cre recombinase under the control of a 
specific promoter, thereby deleting the target gene. In contrast, the target gene should 
remain functional in cells of all other tissues, where the Cre transgene is not expressed 
that is, the promoter controlling the Cre recombinase is inactive. It was shown that Cre 
could be used at a high efficiency to excise a transgene in vivo (Orban et al., 1992). Cre 
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expressing mice were used to inactivate for the first time an endogenous mouse gene 
(DNA ploymerase beta gene) (Gu et al., 1994). The terminology of the conditional 
knock-out was also applied to the NMDA receptor subunit 1 gene (Tsien et al., 1996a, b). 
The DNA excising capability of Cre recombinase can also be used to turn on a foreign 
gene by cutting out an intervening stop sequence between the promoter and the coding 
region of the transgene (Tsien et al., 1996a). The Cre/loxP system is a valuable tool for 
molecular biology in that, it allows the isolation of individual genes and their functions 
by establishing tissue specific expression.  
 
Functional inactivation of the NR2B alleles is achieved specifically in forebrain principal 
neurons by breeding with the transgenic mice TgCre4 in which Cre recombinase is 
expressed by the α- Ca2+ calmodulin dependent protein kinase II (α-CaMKII) promoter 
(Mantamadiotis et al., 2002). In these mice Cre is expressed in the postnatal forebrain, in 
pyramidal neurons but not in interneurons. 
 
2.2 The Lentiviral System as a Tool for Gene Delivery 
 
To achieve transgene expression, different viral vectors were applied in different tissues. 
The most widely used virus types have been adenoviruses (AV), adeno-associated viruses 
(AAV), herpes simplex virus (HSV), different RNA viruses and retroviruses. In this 
study the lentivirus, a member of the retroviruses, was used for in vivo gene delivery into 
the mouse hippocampus. 
 
Retroviruses are positive-strand RNA viruses. After entering the host cell the virus 
reverse transcribes its genome from RNA into DNA. It is this DNA form of the retrovirus 
that integrates into the host-cell genome. Lentiviruses are a class of retroviruses that 
cause chronic illnesses in the host organisms they infect. Among retroviruses, they have 
the distinguishing property of being able to infect non dividing cells in addition to 
dividing cells, and this ability has led to their development as gene delivery tools (Naldini 
et al., 1996). Besides, lentiviruses have gained a lot of attention as gene delivery tool due 
to their very low immunogenicity. Lentivirus based vectors were derived from many 
different lentiviruses, such as feline immunodeficiency virus (FIV), human 
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immunodeficiency virus type I (HIV-1), bovine immunodeficiency virus (BIV) (Azzouz 
et al., 2004; Quinonez and Sutton, 2002). Since they are the best characterised, HIV 
lentiviruses are the most frequently used in gene delivery.  
 
The lentiviral expression vector system is composed of three plasmids which produce 
viral particles that are infectious but not contagious (Figure 9): 1) The transfer vector to 
express the cassette of interest, 2) The packaging vector coding for trans-acting elements 
necessary for efficient virus replication and maturation, 3) The vector expressing 
envelope glycoprotein (Naldini et al., 1996).  
 
Vector expressing gene of interest
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Figure 9: Three components of the self-inactivating lentiviral system (Adapted from A. Cetin Master 
Thesis, 2004). 
A) Vector of gene of interest: expression of Cre recombinase and EGFP is driven by the α-CaMKII 
promoter. IRES= internal ribosomal entry site, WRE= woodchuck hepatitis virus posttranscriptional 
regulatory element, LTR= long terminal repeat. B) The packaging vector encodes the information for 
packing the vector RNA. The RNA encodes for the viral structural proteins: Gag (matrix, capsid and 
nucleocapsid proteins) and Pol (protease, reverse transcriptase and integrase), in addition the accessory 
proteins TAT and REV. The vector is devoid of the genes related to HIV pathogenesis (∆vif, ∆vpr, ∆vpu, 
∆nef). hCMV (human cytomagalovirus (CMV) promoter, Dψ= packaging signal deletion, RRE= rev-
response element. C) the third component is the packaging deficient VSV-g vector (Vesicular Stomatitis 
virus envelope glycoprotein).  
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The first component, the transfer vector, contains a packaging signal and will be packed 
into the newly generated viral particles. This vector is devoid of the gene coding 
sequences from the original HIV vector. Lacking these cis-acting elements, the transfer 
vector will be able to transduce target cells but will be unable to replicate. This way, 
biosafety of the system is enhanced. The HIV-1 flap sequence, which regulates nuclear 
transport, increases the transduction rate of the infected cells. Introduction of the 
woodchuck regulatory element (WRE) into the transfer vector close to its 3` end, was 
shown to facilitate nuclear export of the viral transcript. Its presence also results in higher 
virus titers (Ramezani et al., 2000).  
 
To achieve efficient gene-of-interest expression from the lentiviral backbone, different 
internal promoters can be used for targeting different cell types. In this study the α-
CaMKII promoter which was characterised by A. Cetin in Prof. Seeburg`s group was 
used.  
 
The second component, the packaging vector, encodes all necessary and sufficient 
proteins for packaging. In addition, it lacks the accessory genes vif, nef, vpu, vpr related 
to HIV pathogenesis but not necessary for infectivity (Kim et al., 1998). 
 
The third component contains the envelope glycoprotein which is necessaray for the 
tropism and the infectivity of the produced viral particles. When the particles are 
pseudotyped (the process of generating viral particles that contain the genome of one type 
of virus and the structural genes of another) with vesicular stomatitis virus glycoprotein 
(VSV-G), the vector can serve to introduce genes into a broad range of tissues (Burns et 
al., 1993).  
 
In all 3 vectors of the expression system, U3 from the 5’ LTR (long terminal repeat) was 
replaced by the CMV (cytomegalovirus) promoter. In addition, the U3 region of the 3’ 
LTR was also altered. As a result both LTRs became inactive and this makes the 
transgene vector unable to replicate after infection. These modifications add additional 
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safety features to the HIV-1 based lentivirus vector system. Such inactive LTR-lentiviral 
vectors are named as self-inactivating (SIN) vectors.  
 
In this study, lentiviral mediated gene delivery was used in vivo for Cre/loxP 
recombination. The lentiviral particles express Cre recombinase and the GFP protein 
under the control of the α-CaMKII promoter. The gene of interest to be delivered was 
cloned by Valerie Grinevich, in Prof. Seeburg´s group. 
 
2.3 Purpose of the Project 
 
It has been hypothesized that the developmental switch from NR2B to NR2B+ NR2A at 
synaptic sites may be responsible for the decreased plasticity observed in older animals 
(Carmignoto and Vicini, 1992; Crair and Malenka, 1995). Interestingly, mice 
overexpressing NR2B show enhanced LTP (Tang et al., 1999) and improved performance 
in behavioural tests for learning and memory (Tang et al., 1999; Wong et al., 2002) 
whereas mice lacking the NR2B subunit die at birth (Kutsuwada et al., 1996). Perinatal 
lethality of NR2B knock-out indicates the importance of this subunit during CNS 
development and calls for a conditional knock-out of the NR2B gene.  
 
This dissertation entails 1) generation and analysis of the NR2B2lox mouse line with an 
exon flanked by loxP sites, 2) generation and analysis of the NR2B∆Fb mice by breeding 
NR2B2lox mice with the transgenic mice TgCre4 in which Cre recombinase is expressed by 
the α- Ca2+ calmodulin dependent protein kinase II (α-CaMKII) promoter (Mantamadiotis 
et al., 2002). In NR2B∆Fb mice, Cre is expressed in the postnatal forebrain, in pyramidal 
neurons but not in interneurons. In addition, analysis of the ablation of the NR2B in CA1 
pyramidal cells of the NR2B2lox mice was performed by using  viral mediated gene 
delivery in vivo for Cre/loxP recombination.  
Further behavioural studies of the NR2B∆Fb mice will help to elucidate the functional 
importance of the NR2B subunit in learning and memory during adulthood. 
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2 MATERIALS AND METHODS 
 
2.1 Materials 
 
Common chemicals were purchased from the following companies: 
 
Amersham Biosciences, Freiburg    MBI Fermentas, St.Leon-Rot 
AppliChem, Darmstadt     Merck, Darmstadt 
Becton & Dickinson, Heidelberg              New England Biolabs  
(NEB), Frankfurt A.M. 
Bio-Rad, München      PEQLAB, Erlangen 
Biozym, Hameln      Roche, Mannheim 
Fluka, Neu-Ulm      Roth GmbH, Darmstadt 
Invitrogen, Karlsruhe      Sigma-Aldrich, München 
 
2.1.1 Special Chemicals 
 
Agar         Invitrogen 
Agarose        Invitrogen 
Bacto Tryptone       Becton & Dickinson 
Bacto Yeast Extract       Becton & Dickinson 
5-Brom-4-chlor-3-indolyl-β-D-galactopyranosid (X-Gal)  PEQLAB 
Bromophenolblue       CHROMA 
Ethidiumbromid       Serva 
Ethanol        Sigma-Aldrich 
Ficoll, Type 400       Sigma 
Isopropyl-β-D-thiogalactosid (IPTG)     PEQLAB  
Isopropanol        Applichem 
3-(N-Morpholino)-propansulfonic acid (MOPS)   Sigma 
Natriumdodecylsulfat (SDS)      AppliChem 
Polyethylenglycol 6000 (PEG)     Sigma 
Polyvinylpyrrolidon (PVP)      Sigma 
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PRISM BigDye Terminator cycle sequencing kit    ABI 
Quikhyb hybridisation solution      Stratagene 
Tris-(hydroxymethyl)-aminomethan (Tris)     Roth 
 
2.1.2 Antibiotics 
 
Ampicillin         Sigma 
Chloramphenicol        Sigma 
Penicillin/streptomycin       Sigma 
Mitomycin C         Sigma 
 
2.1.3 Enzymes and Proteins 
 
RNase inhibitor        Fermentas 
5X Buffer Transcription Buffer      Invitrogen 
NEB buffer         NEB 
0.1 M DTT         Invitrogen 
DNAse (RNAse free)        Invitrogen 
Reverse Transcriptase 
DNase I (pancreatic nuclease)      Roche 
E.coli DNA-Polymerase I (Klenow fragment)    Roche 
T4 polynucleotide kinase       NEB 
Proteinase K         Roche 
RNase A (pancreatic ribonuclease)      Roche 
Taq DNA Polymerase        Invitrogen 
Pfu DNA Polymerase        Stratagene 
T4 DNA Ligase        Roche 
Bovine serum albumin (BSA)      Sigma 
 
Restriction endonucleases were purchased from MBI and NEB. 
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2.1.4 Radioactive Compounds 
 
[γ-32P]ATP   Specific activity:  185TBq/mmol Amersham 
    Radioactive concentration: 370 MBq/ml 
[α-32P]dCTP   Specific activity:  110TBq/mmol Amersham 
    Radioactive concentration: 370 MBq/ml 
 
 
2.1.5 Nucleotides 
 
Adenosine triphosphate (ATP)      Amersham 
Deoxyribonucleotides (dNTP´s)      MBI 
 
2.1.6 Nucleic Acids 
 
DNA size marker:  λ DNA cut with Sty I     MBI 
    pRK7 plasmid DNA cut with Hinf I  MBI 
DNA from salmon sperm       Sigma 
 
2.1.7 Vectors 
 
pBluescript II SK (-)        Stratagene 
 
2.1.8 Buffers and Solutions 
 
For the preparation of aquous solutions desalted water from a "MilliQ Water Purification 
System“ (Millipore) was used. 
 
Chloroform solution     Chloroform/Isoamylalcohol 49:1  
Denaturing solution     1.5 M NaCl 
       0.5 M NaOH 
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Loading buffer     30% Glycerol 
       1% Bromophenolblue and/or 
       1% Xylencyanol FF 
       25 mM EDTA 
IPTG solution      20 mg IPTG/ml H2O 
10x Ligase buffer     500 mM Tris/HCl pH 8.0  
       100 mM MgCl2
       10 mM DTT 
       1 mM EDTA 
Phenol solution     1000 g Phenol 
       250 ml H2O 
1.2 g 8-Hydroxychinolin 
52.6 ml Tris-Base (1M) 
adjust to pH 7 with Tris-HCl (pH 7.6) 
 
Reneutralising solution    1.5 M NaCl 
       1.5 M Tris-HCl pH 7.5 
 
Solution S1      50 mM Glucose 
       10 mM EDTA 
       25 mM Tris-HCl  pH 8.0 
 
Solution S2      0.2 N NaOH 
       1% SDS 
 
Solution S3      3 M Kalium acetate  pH 5,2 
 
20x SSC      3 M NaCl 
       0.3 M Natrium Citrate 
 
TE       10 mM Tris/HCl pH 8,0 or 7,6 
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       1 mM EDTA 
 
Lysis buffer 
10 mM Tris 
100 mM EDTA 
0.5% SDS (Sodium Dodecyl Sulfate) 
TENS buffer  
0.14 M NaCl 
20 M Tris 
5 mM EDTA 
 
TFB I       100 mM RbCl 
       50   mM MnCl2
       10   mM CaCl2
       30   mM KOAc 
       15   % Glycerol (87%) 
       adjust to pH 5.8  
 
TFB II       10   mM MOPS 
       10   mM RbCl 
       75   mM CaCl2
       15   %    Glycerol (87%) 
       filter sterile 
 
20x TAE Puffer     800 mM Tris/HCl 
       400 mM NaOAc 
       40 mM EDTA 
       adjust to pH 8.3 with acetic acid 
 
X-Gal Solution     20 mg X-Gal/ml DMF 
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2.1.9 Media for Bacterial Cultures 
 
All Solutions were sterilised in an autoclav. 
 
2YT medium      16 g/l Bacto Tryptone 
       5   g/l Bacto Yeast Extract 
       5   g/l NaCl 
       adjust to pH 7.5 with NaOH 
 
LB medium      10 g/l   Bacto Tryptone 
       5   g/l   Bacto Yeast Extract 
       10 g/l   NaCl 
       4   mM MgSO4
       10 mM KCl 
       adjust to pH 7.6 with KOH 
 
TB-A       12    g/l   Bacto Tryptone 
       24    g/l   Bacto Yeast Extract 
       0.35%     Glycerol 87% 
 
TB-B       0.17 M    KH2PO4
       0.72 M    K2HPO4 
 
After autoclaving, 450 ml TB-A are mixed with 50 ml TB-B. 
 
2.1.10 E.coli strain 
 
DH5α          Invitrogen 
 
2.1.11 Agar Plates 
 
LB medium is autoclaved with 1,5% Select Agar and cooled down to 50°C before 
preparing plates. 
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Antibiotics, X-Gal and IPTG are added to the cooled media immediately before use. 
 
Ampicillin plates:  200 mg/l     Ampicillin 
 
Ampicillin/X-Gal plates: 200 mg/l     Ampicillin 
    160 mg/l     X-Gal 
    160 mg/l     IPTG 
 
2.1.12 Media for ES Cell Culture 
 
DMEM high glucose        Gibco 
DMSO          Gibco 
 
2.1.13 Special Buffer and Solutions used in ES Cell Culture 
 
MEM-non-essential amino acids      Invitrogen 
Sodium pyruvate        Invitrogen 
LIF (leukemia inhibitory factor)      Invitrogen 
HEPES buffer         Invitrogen 
10x PBS         Invitrogen 
Gelatin         SIGMA 
Trypsin         Invitrogen 
FCS          PAN 
Penicillin, Streptomycin       Invitrogen 
G418          Invitrogen  
ES cell medium    0.1 mM Non-essential aminao acids 
      1    mM  Sodium pyruvate 
      10-4 M β-mercaptoethanol 
      20% FCS 
      150 µg Penicillin, Streptomycin 
      6000 U LIF 
      0.1 M L-Glutamine 
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      DMEM high glucose (500ml) 
         
Feeder cell medium    10% FCS 
      100 µg  Penicillin, Streptomycin 
      0.1 M L-Glutamine   
Freezing medium     20% DMSO, 
      50% FCS 
        in ES cell medium 
Lysis Buffer     100 mM Tris pH 8.3 
      5 mM EDTA  
0.2% SDS 
200 mM NaCl  
0.1 µg/ml Proteinase K 
 
2.1.14 Special Buffer and Solutions for Protein Extraction and Western Blotting 
 
Hepes buffer: (pH 7.4)       ROTH  
Solution A) 10 mM Hepes        
Soluton B)  40 mM Hepes        
  200 mM NaCl      Applichem  
  2% Triton      Merck 
Protease inhibitor cocktail tablets     Roche  
BSA (Bovine Serum Albumin) 10 mg/ml     NEB  
Bradford (dye reagent concentrate)     NEB  
Triton         Merck 
SDS-PAGE gels  
30% Acrylamid/Bis solution      Bio-Rad  
10% SDS (Sodium Dodecyl Sulfate)     Applichem  
 
TEMED (N,N,N’N’-Tetra-methylethylenediamine)   Bio-Rad 
10% APS (Ammonium Persulfate)     Bio-Rad  
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Tris (0.5 M,1.5 M)  Tris base     ROTH  
 
Running buffer 
           Tris base       ROTH  
           Glycine       Applichem  
           SDS (Sodium Dodecyl Sulfate)    Merck  
 
Transfer buffer  
        Tris base        ROTH  
        Glycine        ROTH 
        Methanol (10%)       Merck 
Loading buffer: Laemmli Sample buffer    Bio-Rad  
Milk powder        ROTH  
Ponceau S staining solution      Sigma  
Tween 20 (electrophoresis reagent)     Sigma  
 
Protein marker: Bench Mark TM Prestained Protein ladder   Invitrogen  
Nitrocellulose transfer membrane     Amersham  
ECL solution (ECL plus Western Blottiong detection)  Amersham  
Hyper filmTMECL       Amersham  
 
Antibodies:  
rabbit anti-NR2B polyclonal antibody    Chemicon  
mouse anti-NR2A monoclonalantibody     MPI, Heidelberg 
rabbit anti-GluRA polyclonal antibody    Upstate 
mouse anti-GluRB monoclonal antibody    Chemicon 
monoclonal anti-actin antibody     Sigma  
rabbit anti-Cre antibody      BAPCO 
anti-rabbit Cy3     Jackson Immunoresearch Labaratories  
anti-rabbit IgG, antibody linked whole peroxidase horseradish Vector  
anti-mouse IgG, antibody linked whole peroxidase horseradish Vector  
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Mowiol 20% in 0.2M Tris/HCl pH 8.5   DABCO 
 
2.1.15 Special Articles 
Bio-Spin 6 Chromatography columns    Bio-Rad 
Filter paper        Schleicher&Schuell 
Gene Pulser cuvettes (2 mm, 4 mm)     Bio-Rad 
Sterile filter units 185 mm      Millipore 
Chromaspin 100 (1000) TE columns     Clontech 
Hybond nylon, 0,45 Micron      Amersham 
X-ray films Kodak X-OMAT AR     Kodak 
 
2.1.16 Kits 
 
QIAquick Gel Extraction Kit      QIAGEN 
QIAquick PCR Purification Kit     QIAGEN 
QIAfilter Plasmid Maxi Kit      QIAGEN 
Rediprime II DNA Labelling Kit     Amersham 
 
2.1.17 Primers 
 
10 mM                                                    Invitrogen Custom Primers 
ex 6-5: GTGGTCATGAAGAGGGCCTACA (22nt) 
ex 6-3: CTAAGAAGGCAGAAGGTGACACA (23nt) 
ex 5-5: GACCTTTACCTGGTGACCAATG (22nt) 
ex 5.5..2:AACAGATGAGGAACCAGGCTAC (20nt) 
ex 8.3seq: CAAATCGCTTTGCCCGATGGTGA (20nt) 
ex 8-3: CAGGCCGGAAACCTGGTCCA (20nt) 
rspcre1: ACCAGGTTCGTTCACTCATGG (21nt) 
rspcre2: AGGCTAAGTGCCTTCTCTCTACAC (22nt) 
rspneo4: GGCTATTCGGCTATGACTGGGC (22nt) 
rspneo5: GGGTAGCCAACGCTATGTCCTG (22nt) 
i6-BD3´: GAGTTGCCTCCATCATTGTGTC (22nt) 
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i6-BD5´ : AGTCTCCTCTTCATCCTCAGTG (22nt) 
TS-2Bscr5-f: ATCCACCTGTTTCTGCTTCC (18nt) 
TS-2Bscr5-r: CATATTGCTAAGGCTAAGCTAGCTT (23nt) 
TS-2Bscr3-f: GATCCCAGGATTCCAAGACC (18nt) 
TS-2Bscr3-r: GCCTCCATATGTCAATATTGGAT (21nt) 
 
2.2 Methods 
 
2.2.1 Microbiological Methods  
 
2.2.1.1 Preparation of Competent E. coli Cells 
 
a) Chemocompetent Cells 
500 ml of LB medium is inoculated with 1 ml of a fresh overnight culture of DH5α 
bacteria and incubated at 37°C on a shaker until the OD600 equals 0.5 to 0.7. The cells are 
cooled on ice and spun down for 5 minutes at 2600g in a JLA 250-rotor (Beckmann). The 
bacteria are suspended in 10 ml TFB I, mixed with another 140 ml TFB I and incubated 
on ice for 2 hours. After a second centrifugation the bacteria are suspended in 20 ml TFB 
II. Aliquots of 100 µl are frozen in liquid nitrogen and stored at –70°C. 
 
b) Electrocompetent Cells 
750 ml LB medium is inoculated with 7.5 ml of a fresh overnight culture and incubated at 
37°C on a shaker until the OD550 equals 0.75. The cells are spun down at 2600 g, the 
supernatant is decanted and he pellet is suspended in 750 ml 10% glycerol. This 
procedure is repeated. The bacterial pellet is finally resuspended in the residual liquid 
until the OD550 is 200-500. Aliquots are prepared as explained above. 
 
 
 
 
 
 
2.2.1.2 Plate Culture for E.coli Cells 
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With a sterile wire a colony of E.coli is striked out on an agar plate containing the 
appropriate antibiotic. After 12 hours of incubation at 37°C the plate is stored at 4°C. The 
bacterial 
plates can be kept up to 4 weeks to set up liquid cultures. 
 
2.2.1.3 Transformation of E.coli by Heat-shock 
 
100 µl of chemocompetent cells are mixed with 1 ng plasmid DNA or 10 ng ligated 
vector and put on ice for 20 minutes. A heat-shock at 37°C for 90 seconds is then 
performed. Following heat-shock the sample is transferred to ice and 400 µl medium 
(2YT) is added. After an incubation at 37°C for 15-30 minutes the bacteria are distributed 
on a agar plate. 
 
2.2.1.4 Transformation of E.coli by Electroporation 
 
One third of a butanol precipitated ligation is mixed with 50 µl electrocompetent cells 
and electroporated in a cuvette with a gap of 2 mm between the electrodes. The 
electroporator settings are 2.5 kV/25 µF/200-400 Ω. The bacteria is mixed with 1 ml 2 
YT medium, incubated at 37°C for 30 minutes and distributed on 3 plates. 
 
2.2.2. Isolation and Purification of Nucleic Acids  
 
2.2.2.1 Preparation of Plasmid DNA by Alkaline Lysis 
 
a) Mini-Preparation 
One colony is isolated with tootpick from the plate to a glass tube containing 2 ml TB 
medium and the appropriate antibiotic. After incubation on a rotating wheel at 37°C for 
14 hours (for the growth of the bacteria) the suspension is transferred to a reaction tube 
and spun down. After discarding the supernatant the bacterial sediment is resuspended in 
200 µl S1 (100 ng/µl RNAse A) and mixed with 200 µl S2. The mixture is incubated 5 
minutes at room temperature to lyse the cells completely. After the addition of 200 µl of 
 39
Materials and Methods 
S3 centrifugation at 13000 rpm for 15 minutes at 4°C is performed. The supernatant is 
transferred to a fresh tube and precipitated with 400 µl isopropanol, washed with 70% 
ethanol, dried and dissolved in an appropriate volume of TE buffer. 
 
b) Maxi-Preparation (Qiagen Plasmid Kit) 
100 ml of TB overnight culture is centrifuged and resuspended in buffer P1. Addition of 
buffer P2 is followed by 5 minutes incubation at room temperature. Mixing with buffer 
P3 is followed by 20 minutes incubation on ice. The precipitate is centrifuged for 30 
minutes at 20000g and the supernatant is applied to a column. Using different pH and 
ionic concentrations of buffer the proteins and the RNA are washed from the column 
(twice 30 ml buffer QC). The washed plasmid DNA is eluted with 15 ml buffer QF. After 
isopropanol precipitation and 70% ethanol wash, the DNA is dissolved in TE buffer. 
 
2.2.2.2 Ethanol/Isopropanol Precipitation  
 
Ethanol precipitation is used to concentrate nucleic acids, or to transfer them into a new 
set of buffer and salts. 0.1 volumes of 3 M sodium acetate, pH 5.5 are added to the DNA 
solution, together with 2 volumes of absolute ethanol or 0.7 volumes of isopropanol and 
mixed well. 10-20 minutes centrifugation at 14000 rpm is performed. After decanting the 
supernatant, in order to remove the salt the pellet is washed with 70% ETOH. The dried 
pellet is dissolved in TE buffer. 
 
2.2.2.3 Phenol-Chloroform Extraction 
 
Phenol is used to denature and remove proteins from nucleic acid solutions. Equal 
volumes of phenol and chloroform containing 4% isoamyl alcohol are added to the DNA 
solution to be purified. The phases are mixed and centrifuged 4 minutes in a microfuge at 
14000 rpm at room temperature. Two phases are formed; the phenol (on the bottom) and 
the aquous (on top) and in between a white interface layer of denaturated proteins. The 
aqueous phase (which contains the nucleic acids) is transferred to a fresh tube. The 
phenol extraction can be  followed by an extraction with chloroform containing isoamyl 
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alcohol, to remove residual protein as well as phenol, which might remain from the 
previous phenol extraction. Again the mix is centrifuged and the aqueous phase (usually 
the upper phase) is recovered. The upper phase with the nucleic acids is transferred to a 
fresh tube and precipitated by isopropanol or (100%) ethanol. 
 
2.2.3 Manipulation and Analysis of DNA 
 
2.2.3.1 Restriction Digest of DNA  
 
Restriction digest of DNA serves to linearize circular DNA, to cut out specific fragments 
from a larger molecule and to cut genomic DNA. It is perfomed for analytical purpose 
(e.g identification of plasmid, a targeting event in genomic DNA) or preparative purpose 
(e.g isolation of fragment for cloning). 1 Unit (U) of restriction enzyme is the amount 
necessary to digest 1 µg of a specific DNA in one hour in a volume of 50 µl. For 
analytical purposes 100-500 ng of plasmid DNA are digested with one or more restriction 
enzymes (1-5 units each) in a volume of 10-20 µl for one hour and separated on an 
agarose gel. 
 
2.2.3.2 Ligation of DNA 
 
The enzyme DNA ligase of the phage T4 catalyses the formation of a phosphodiester 
bond between a 3´-OH and a 5´-phosphate. In this way fragments with sticky ends (single 
stranded 5´- or 3´- overhang) or blunt ends can be ligated, if at least one of the fragments 
has a 5´-phosphate. The enzyme needs ATP as a cofactor. In the ligation mix the 
molecular ratio of vector to insert in general is 1:5, if the fragments are very small for 
example adaptors it is 1:1000. The reaction takes place in a volume of 20 µl. This mix 
contains 10 nmole ATP, 2µl 10X ligation buffer and 1 unit T4 DNA ligase. Incubation 
can take place at 16°C overnight, in order to prolong the activity of the enzyme, 
especially for “blunt end”-ligations. In “shutgun”-cloning the fragment to be cloned and 
the cloning vector are digested together, and then ligated without seperation of the 
fragments on a gel. 
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2.2.3.3 Agarose Gel Electrophoresis 
 
Agarose gels serve to separate linear DNA fragments (for identification purification and 
isolation). Separation takes place in a grid-like matrix of agarose through which smaller 
fragments can pass more quickly than larger fragments. Ethidium bromide is added to the 
gel to visualise DNA fragments by its fluorescence in UV light. To determine the length 
of the fragments a DNA size marker with known fragment sizes is separated in parallel. 
By varying the concentration of agarose (0.7-2%) separation in the high or low molecular 
range is favored. The required amount of agarose is dissolved in 100 ml 1X TAE buffer 
by boiling, ethidium bromide is added to the solution (0.5 µg/ml final) and the gel poured 
into a gel tray with combs. 
 
2.2.3.4 Cycle Sequencing Reaction 
 
The sequencing method is based on the principle of Frederik Sanger according to which 
randomly built-in dideoxynucleotides (ddNTP`s) lead to a chain termination of the 
polymerase reaction. The four ddNTP`s are coupled to dyes fluorescent at different wave 
lengths. The sequence of the DNA can be determined by laser beam detection after 
separation in a capillary gel. The reaction occurs in analogy to a PCR reaction, however 
only one primer is added. The sequencing of plasmid DNA and PCR products takes place 
according to the “Dye Terminator Cycle Sequencing”-protocol of ABI. A sequencing mix 
of 10 µl contains approximately 1 µg of plasmid DNA, 5 pmol of primer and 4 µl of 
“BigDye Ready Reaction Terminator Cycle Sequencing Kit”. The reaction needs 25 
cycles with the following conditions: 15 seconds at 95°C, 15 seconds at 55°C, 4 minutes 
at 60°C. Afterwards the reaction is filled up to 100 µl with H2O. The DNA is precipitated 
with acetate and ethanol, washed and dried. 
 
2.2 3.5 Southern Blot Analysis 
 
Southern blotting is the transfer of DNA fragments from an electrophoresis gel to a 
membrane support. The transfer of DNA fragments is based on the principle of capillary 
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diffusion from an agarose gel onto a nylon or nitrocellulose membrane, using a high-salt 
transfer buffer to promote binding of DNA to the membrane. The DNA to be analysed is 
separated by agarose gel electrophoresis. To have a good quality of seperation low 
voltage is applied (e.g 50 V). In order to visualise under UV light, staining of the gel with 
ethidiumbromide is performed after the seperation. The pictures are taken using a 
fluorescent ruler. In order to facilitate the transfer of bigger fragments (>5kb) the gel is 
incubated on a shaker in 0.25 M HCl for 30 minutes, followed by 2x 15 minutes in 
denaturation buffer, twice for 15 minutes in reneutralisation buffer and  a final incubation 
in 5x SSC for 15 minutes. To set up the blot a glass or plastic dish is filled with 20x SSC. 
A solid support is put inside the dish and covered with a filter paper which is in contact 
with the solution at both sides. The gel is placed on the filter paper and the surface is 
covered with a nylon membrane of equal size. 5 filter papers and 5 cm thick paper towels 
are put on the membrane avoiding air bubbles. A glass plate with a weight on it is placed 
on top to hold everything on place. The region between the edges of the gel and the dish 
is covered with plastic wrap. After 6 hours of transfer, the position of the wells in the gel 
is marked on the membrane and the DNA is fixed using UV cross-linking. 
 
2.2.3.6 Hybridization and Washing of the Membrane  
 
A denaturated radioactive probe binds to DNA fragments with sequences complementary 
to it. This way DNA fragments can be visualised on the membrane by exposing to X-ray 
film. Prehybridization is performed by using the Quick-Hyb buffer for 10-20 minutes at 
68°C. The labelled probe is mixed with salmon sperm DNA, denaturated and added to the 
hybridization buffer, after which hybridization takes place for 1-2 hours on a shaker or in 
rotating glass tubes. After hybridisation, the membrane is washed twice with 5x SSC, 
0.1% SDS at room temperature for 15 minutes and once with 1x SSC, 0.1% SDS at 68°C 
for 20 minutes. The membrane is wrapped in platic film and exposed to a X-ray film. 
 
2.2.3.7 Polymerase Chain Reaction 
 
PCR is an alternative method for amplification of DNA fragments up to 5 kb in a shorter 
time. Fragments of 50 kb can also be obtained by using special kits. Adjacent sequence of 
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the fragment of interest has to be known in order to synthesize the two primers. These 
primers can be elongated by a thermostable DNA-polymerase. The number of DNA 
molecules increases with the number of elongation cycles in an exponential way. The 
typical PCR program consists of an initial denaturation step of 1-5 min at 94°C followed 
by 30 cycles of denaturation for 30 seconds at 94°C, annealing for 30 seconds at 55°C, 
elongation for 90 seconds at 72°C, and an additional 5 minutes of final elongation at 
72°C. The reaction is cooled down to 4°C at the end. 
 
The annealing temperature depends on the primer. It should be 5°C below the calculated 
melting temperature (Tm). The number of cycles is determined by the number of template 
molecules. In general 20-25 cycles are performed on cloned DNA, 30-35 cycles on 
genomic DNA or cDNA, in order to prevent accumulation of false incorporation not 
more than 25 cycles should be performed for generation of preparative fragments. In 
addition to the DNA template and in general two primers, MgCl2, dNTP´s, a thermostable 
DNA-polymerase and the appropriate buffer are necessary. 
A polymerase with “proofreading ability” (3’ to 5’ exonuclease activity) is preferred for 
preparative purposes.  
 
2.2.4 Propagation and Maintanance of Embryonic Stem (ES) Cells 
 
2.2.4.1 Transfection of Embryonic Stem Cells with the Targeting Construct 
 
All procedures described below are performed in a cell culture room under a laminar flow 
hood 
 
a) Growing ES Cells for Electroporation 
A number of different ES cell lines are available. For this project the cell line R1() was 
used. The ES cells grow on monolayers of mitotically inactivated fibroblast cells. For this 
reason mitomycin treated feeder cells (1.3 x 106 cells for 6 cm plate and 4 x 106 cells per 
10 cm plate) are thawed at 37°C and resuspended in 5 ml feeder cell medium. After 
centrifugation at 1000 rpm for 5 minutes, the pellet is resuspended and the cells are 
distributed to one 6 cm plate and two 10 cm plates containing feeder medium. After 24 
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hours the medium is changed to ES cell medium. A vial of ES cells is thawed at 37°C and 
resuspended in 10 ml ES cell medium. After centrifugation at 1000 rpm for 5 minutes, the 
pellet is dissolved in ES cell medium and transferred to the 6 cm feeder plate prepared 
previously. The ES cell medium is changed daily until the cells become confluent. The 
ES cells are split (trypsinized, incubated at 37 °C, spun down at 1000 rpm for 4 min, and 
resuspended in ES cell medium) when they become confluent and transferred to the two 
10 cm plates containing the mitomycin treated feeder cells. The ES cell medium is 
changed daily until the cells reach confluency and can be used for electroporation. 
 
b) Electroporation of ES Cells 
This method is used to introduce DNA into embryonic stem cells for gene targeting 
experiments. Technically this method is relatively simple compared to others. DNA can 
be transfected into ES cells by application of a high voltage electrical pulse to the 
suspension of cells and DNA. After application of this pulse the DNA passes through 
pores in the cell membrane. 
 
30 µg sterile, linearized plasmid DNA is dissolved in 100 µl PBS. ES cells are 
trypsinized, centrifuged at 1000 rpm for 5 minutes and the pellet is resuspended in 20 ml 
ES cell medium, and distributed on a plate covered with gelatin in order to separate the 
ES cells from the feeder cells. After an incubation of 20 minutes, the medium is 
collected, the plates are rinsed with ES cell medium, and the cells are pooled in a 50 ml 
conical tube. This procedure is repeated. The number of cells is adjusted to 10x106 in 0.7 
ml PBS. 80-150 µl PBS containing 30 µg of DNA is mixed with 0.7 ml of the cell 
suspension. The mixture is transferred to a pre-chilled electroporation cuvette and is 
electroporated at 240 V, 500 µF. After 20 minutes of incubation on ice the cells are 
transferred to ES cell medium to be distributed on 5 gelatin covered plates. From the third 
day on 200 µg/ml G 418 is added to the ES cell medium. After growth in this selective 
medium for 8-10 days clones can be picked. 
 
c) Picking ES Cell Clones 
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The ES cell clones, surviving the selection in G418 containing medium are picked under 
a dissecting microscope when the diameter is 0.5-2 mm. On the evening before picking 
mitomycin treated feeder cells are distributed to flat-bottom 96-well plates. Two hours 
before picking, the medium on the plates containing the clones is changed to ES cell 
medium. The plates are washed twice with PBS before picking under the microscope. 
Picking is performed, by sucking a clone into a 200µl pipet tip. The picked clones are 
distributed to a round-bottom 96 well dish containing 50 µl 1/2x trypsin (1:1 
trypsin:PBS) per well. The picked trypsinised colonies are then split to the flat-bottom 96 
well master plates containing feeder cells, and to 24 well plates covered with gelatin. 
 
d) DNA Isolation from ES Cell Clones for Genomic Southern Blot 
DNA is prepared from cells, which are grown on gelatin to confluency. Cells are washed 
twice with PBS. 500 µl lysis buffer is added to each well. The suspension is incubated at 
37°C overnight. Thus, the cells are lysed and DNAses are digested. Isopropanol (500 µl) 
is added and incubated on a shaker at room temperature for 10-15 minutes. The 
precipitated DNA is spooled out of the wells, rinsed in 500 µl ETOH 70%, dissolved in 
100-200 µl TE and stored at 4°C. 
 
e) Freezing ES Cell Clones in 96 Well Master Plates 
The media of the 96 well master plate is changed. After two hours the cells containing the 
clones are washed two times with PBS, then 25 µl trypsin is added and left at 37°C for 4-
6 minutes. After checking under the microscope to confirm that the ES cells are split, 75 
µl of pre-chilled freezing medium is added. The plate is sealed in plastic, labelled and left 
at -20°C 1 hour before it is transferred to -70°C. 
 
f) Expansion of the Positive ES Cell Clones 
Positive clones from a master plate are thawed and transferred into falcon tubes 
containing 5 ml ES cell medium. Centrifugation for 5 min at 1000 rpm is followed by 
suspension of the pellet in 3 ml ES cell media and distribution in 3 wells of a 24 well 
plate on feeder cells. After growing to a certain (40%) confluency, the cells are washed 2 
times with PBS and 1.5 ml trypsin is added and incubated at 37°C for 3 minutes. After 
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trituration the cells are transferred in tubes containing 8 ml ES cell medium and 
centrifuged for 4 minutes at 1000 rpm. The pellet is resuspended in 1.5 ml ES cell 
medium and an equal amount of pre-chilled freezing medium is added on ice. The vials 
are left for 1 hour at -20°C, then they are transferred to -70°C. 
 
g) Preparation of ES Cells for Blastocyst Injection 
7 day prior to injection, mitomycin treated feeder cells (1.3 x 106 cells per 6 cm plate and 
4 x 106 cells per 10 cm plate) are thawed at 37°C and resuspended in 5 ml feeder medium. 
After centrifugation at 1000 rpm for 5 minutes, the pellet is resuspended and the cells are 
distributed to one 6 cm plate and two 10 cm plates containing 4 ml and 9 ml feeder 
medium, respectively. A vial of ES cells containing the correctly targeted clone is thawed 
and plated onto the 6 cm plate. The ES cell medium is changed daily until the cells 
become confluent. Meanwhile the medium of the other two 10 cm plates containing the 
feeder cells is changed every 48 hours to feeder medium. On the 4th or the 5th day the ES 
cells are at the appropriate density. The cells are washed two times with PBS and 800µl 
of trypsin is added. After 3 minutes of incubation at 37°C the cells are triturated and 
collected into an falcon tube. Centrifugation at 1000 rpm for 4 minutes is followed by 
resuspension in 5 ml ES cell media. The suspended ES cells are distributed in three 10 cm 
feeder cell containing plates at different volumes (3 ml, 1.5 ml, 0.5 ml). The medium is 
changed daily until the day of injection. At the day of injection the medium is changed 2 
hours before the procedure. Four 10 cm gelatin coated plates are prepared. 1.5 hours 
before the injection splitting procedure is performed (wash with 2 times with 1X PBS, 
trypsinisation ,incubation at 37°C for 3 minutes, trituration, centrifugation at 1000 rpm 
for 5 minutes). Cells are suspended in 10 ml of ES cell media and transferred into the 
prepared gelatin plates for seperation from the feeder cells. Incubation at 37°C. 20 
minutes incubation is followed by another transfer to a second gelatin plate for another 20 
minutes incubation at 37°C. This way the feeder cells are cleaned and ES cells are 
isolated. Transfer of the cells to a tube and centrifugation (1000 rpm, 5 min) are followed 
by resuspension of the cells in pre-chilled feeder medium containing 100 µl hepes buffer 
(20 µl/ml). After this step the cells are ready for blastocyst injection. Blastocyst injection 
was performed by F. Zimmerman. 
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2.2.5 Protein Extraction and Immunoblot (Western Blot) Analysis 
 
Mice are decapitated under anesthesia, and the brains are removed. The hippocampi are 
taken out in 600 µl Hepes buffer A, homogenized and left on ice for 10 min. 
Centrifugation at 1000 g for 10 min at 4°C is followed by addition of Hepes buffer B 
(equal volume as the supernatant) to the supernatant. The potein solution containing the 
combined membrane and cytosolic fractions is mixed for 30 min on a shaker at 4°C. The 
protein concentration is determined by the method of Bradford. Equal amounts of the 
protein are seperated by 10% SDS-PAGE and the proteins are transferred onto 
nitrocellulose membranes by electroblotting. Membranes are blocked with Tris-buffered 
saline containing 0.1% Tween 20 and 5% non-fat dry milk for 1 hour at room 
temperature. The blotted proteins are probed with the following primary antibodies: 
rabbit polyclonal C-terminal anti-NR2B, 1:500; mouse monoclonal C-terminal anti-
NR2A, 1:1000 (provided by MPI Heidelberg); β-actin mouse monoclonal β-actin clone 
AC-15 ascites, 1:8000) Membranes are washed 3 times 15 min for each and are incubated 
with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (1:8000) for 1 
hour. After washing three times bound antibodies are visualized by chemiluminescence 
(ECL Plus; Amersham) and exposed to Hyper filmTM ECL. Quantification of the 
expression levels from western blots were performed by using, adope photoshop, image J 
and microsoft exel programs. 
 
2.2.6 RT PCR 
 
2.2.6.1 RNA Extraction 
 
Total RNA is prepared according to the protocol supplied with TRI REAGENT 
(Molecular Research Labs). RNA is prepared from total brain. Mice are decapitated 
under anesthesia, and the brain is removed. The tissue is homogenized in 2.5 ml of trizol 
in a 15 ml tube, then 500 µl chloroform is added. The phases are mixed well, and 
centrifuged for 20 min. at 4 ˚C, 14 000 rpm. The supernatant containing the RNA is taken 
into a new tube. The RNA is precipitated by addition of 2.5 ml isopropanol. After 
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centrifugation at 14.000 rpm for 20 min at 4 ˚C the supernatant is removed. The RNA 
pellet is washed with 70% ethanol, dried briefly and resuspended in 100 µl DEPC water. 
 
2.2.6.2 Reverse Transcription and PCR 
 
Reverse Transcription-PCR (RT-PCR) is a method used to amplify cDNA copies of a 
RNA: The first step is the enzymatic conversion of RNA to a single-stranded cDNA 
templete. An oligodeoxynucleotide primer is hybridized to the mRNA and is then 
extended by an RNA-dependent DNA polymerase to create a cDNA copy that can be 
amplified by PCR. 
 
a) Reverse Transcription 
50 µg of total RNA, 10 ml of RNase free NEB buffer 2, 1 µg of placental RNAse 
inhibitor (25 u/µg) and 1.5 µl DNAse I (10 u/µl RNAse free) are mixed in a total volume 
of 100 µl and incubated for 1 hour 37 ˚C. After phenol chloroform extraction and ethanol 
precipitation, the RNA is resuspended in 16 µl of DEPC treated water. Subsequently 16 
µl of DNAse treated RNA, 0.5 µl of p(dN)6 (random hexamer primers,1 µg/µl) are mixed 
and incubated for 10 min at 80˚C, and then stored on ice for 5 min. 6 µl of 5x reverse 
transcription buffer, 3 µl dNTPs, 3 µl of 0.1 M dithiothreitol, 1 µl RNase inhibitor (20 
u/µl) are then added, to obtain a final volume of 29 µl. 5 µl of this mixture is taken as 
untranscribed control for mock-reverse transcription. To the remaining 28 µl 1µl of 
MMLV-reverse transcriptase (200 u/µl) is added. Reverse transcription is performed for 1 
hour at 42˚C and then stopped by heat inactivation at 72˚C for 10 min. 
b) PCR 
PCR is performed on 1 µl of transcribed cDNA and 1 µl of untranscribed control (to 
exclude DNA contaminations). PCR is performed for 32 cycles in a total volume of 70 
µl.  
 
2.2.7 Genotyping of Mice 
 
a) By PCR 
For genotyping DNA is prepared from the tip of a mouse tail (0.3-0.5 cm). The tails are 
lysed overnight on a shaker at 1000 rpm at 55 °C in 500µl of TENS buffer containing 0.5 
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mg of proteinase K at 55°C. Afterwards the debris is spun down at 13000 rpm for 5 min. 
600µl of isopropanol is added to the supernatant, mixed, and spun down for another 10 
min. The supernatant is discarded and the DNA pellet is washed with 70% ethanol, dried 
and dissolved in 100 µl TE buffer. PCR reaction is performed for 35 cycles. 
 
B) By Genomic Southern Blot 
For Southern blot analysis liver DNA is prepared because the quality of the DNA is better 
compared to tail DNA. 
Mice are decapitated under anesthesia, and the liver is removed. 1/3 volume of the liver is 
taken into 2 ml of TENS buffer containing 1.5 mg of proteinase K and lysed overnight on 
a shaker at 55°C. Afterwards 2 ml of phenol-chloroform (1:1) mixture is added to the 
debris and mixed on a shaker at room temperature (RT). The mixture is centrifuged at 
3000 x g for 5 min (RT). The supernatant is taken into a fresh 15 ml tube containing 2 ml 
phenol-chloroform (1:1). Mixing on a shaker for 20 minutes is followed by another 
centrifugation (3000 x g for 5 min RT). To the upper phase the same volume of 
chloroform is added and mixed on a shaker for 20 minutes (RT). After centrifugation 
(3000 x g for 5 min RT) the upper phase is extracted a second time with chloroform. The 
upper phase containing the DNA is then precipitated by addition of ethanol. The pellet is 
dried and according to the size dissolved in 500-800 µl of TE buffer.  
The Southern blot analysis is explained in detail in the previous section (2.2.3.5). 
 
2.2.8 Immunohistochemistry 
 
250 µm thick hippocampal slices are fixed with 4% paraformaldehyde in PBS for 3 to 4 
hours. The sections are washed in PBS 3 times for 10 minutes at room temperature, 
permeabilisation and blocking are achieved by incubation in 1% triton and 10% NGS in 
PBS on a shaker at room temperature overnight. The slices are incubated in PBS with 1% 
NGS and 0.5% Triton X-100 with the primary antibody, for 4 hours at room temperature. 
For visualisation of the primary antibody, the slices are washed three times in PBS and 
incubated with the secondary antibody in PBS with 1% NGS and 0.5% Triton X-100 for 
2 hours at room temperature. As a primary antibody rabbit anti-Cre (BAPCO), 1:5000, 
and as secondary antibody antirabbit Cy3 (Jackson Immuno Research Labaratories Inc., 
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West Grove, PA), 1:250, are used. After incubation with the secondary antibody the 
slices are washed three times for 10 minutes with PBS and mounted on glass slides, 
embedded in Mowiol and coverslipped. For analysis an upright fluorescent microscope 
(Zeiss Axioplan 2; Zeiss Goettingen, Germany), containing a Zeiss filter set 10 for 
detection of EGFP (excitation filter BP 450-490; dichroic mirror FT 510; emission filter 
BP 515-565) and filter set 15 for detection of Cy3 (excitation filter BP 546/12; dichroic 
mirror FT 580; emission filter LP 590) is used. 
 
2.2.9 Stereotactic Injection of Lentivirus into Hippocampus CA1 
 
Lentivirus preparation and purification was done by Prof. Seeburg´s group, according to 
production protocols of Carlos Lois. 
A calibrated stereotactic instrument is used to precisely locate the site and depth of 
injections for delivery of the lenti-viruses. The injections are made with a fine glass 
capillary which is prepared with a capillary puller. The fine tip of the capillary is cut at 1-
2 mm from the end for smooth loading and injection. All surgery instruments are kept in 
sterile solution, and washed in distilled water before use. To start a surgery the animal is 
anesthesized with (“ketamine + xylasine”) mix in PBS (6.5mg/ml of ketamine, 1.4 mg/ml 
of xylasine) at a volume of 10 µl/g according to the body weight of the animal. The 
anesthetic solution is injected subcutaneously to the abdominal region. After the animal is 
deeply sedated, the fur covering the region of surgery is shaved. The animal is then put 
on a heat blanket to keep the body temperature at 37°C. After checking the reflexes to 
make sure that animal is deeply anesthesized, the head is fixed in the stereotactic frame 
with appropriate ear bars, by targeting the ear canal. The region for surgery is then 
cleaned with ethanol and the eyes are covered with PBS soaked tissue. The head skin is 
cut in a saggital direction, and fixed with hooks at each side. A tiny hole (~ 1mm in 
diameter) is opened in the skull using a dental grill until right before the dura mater at the 
region of interest. The thin layer of bone that is left between the dura and the outside is 
then very carefully opened with the tip of a needle to the side avoiding any damage to the 
brain. To proceed for the injection, sometimes a very fine cut in the dura mater is 
necessary, especially if the animal is old. To inject the virus, first the virus solution is 
back-loaded into a capillary from the tip by applying suction at the open end of the 
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capillary from a 50 ml syringe. The virus is then injected to the area of interest by 
controlling the coordinates via stereotaxy. Once the desired depth is reached the virus 
solution is injected by applying very little pressure with the syringe. The amount of 
injection is determined by the distance covered by the upper surface of the viral solution 
in the capillary. Usually ~ 50-100 nl of volume is injected. To avoid spill-over of the 
virus solution the tip of the needle is left at the injection site for additional 2 minutes. The 
skin is the sewed and 50 µl of lidocaine is injected subcutaneously at the area of surgery 
to avoid pain after the recovery from general anesthesia. During the recovery period the 
animal is kept on a heat blanket. After the recovery it is transferred to its cage and fed 
with wet food. Animals are kept for 3 weeks before analysis. 
 
2.3 Computer Programs 
 
Adope Photoshop 
Canvas 8.0.3 
DNA Strider 1.3 
EditSeq 
EndNote 6.0 
ImageJ version 1.30 
Microsoft Word  
Microsoft Excel 
Microsoft Explorer 
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3 RESULTS 
 
3.1 Generation of Mouse Line NR2B2lox
 
3.1.1 Generation of the Targeting Construct 
 
Since the general NR2B knock-out is lethal, a conditional knock-out of the NR2B gene 
might elucidate the physiological function of NR2B subunit.  
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mRNA quantification from the wild-type allele versus the mutant allele in heterozygous 
mice, a silent mutation creating an Age I site was introduced into the exon 6 (Figure 11). 
PCR primers were designed for RT-PCR and sequencing, which will be explained in 
detail in chapter 3.2.1. As a positive selection marker, a neomycin resistance gene (neo) 
under the control of the HSV promoter and flanked by two frt sites was also introduced in 
intron 6. Due to possible interference with the splicing process, the neomycin cassette can 
lead to an alteration of gene expression. Thus, it is desirable to remove the neomycin 
cassette either in embryonic stem cells by transient expression of the Flp recombinase or 
in the heterozygous mouse by mating with a so-called “deleter mouse” expressing the Flp 
recombinase under the control of the actin promoter (Rodriguez et al., 2000). Two arms 
of 3.4 kb and 5.1 kb, respectively, serve for homologous recombination (Figure 11). 
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into the embryonic stem cells, it is in most cases randomly integrated into the mouse 
genome. To ascertain that not only homologous recombination in ES cells has occurred 
but also to guarantee the presence of the neomycin cassette and both loxP sites, a 
Southern blot analysis was performed. For this reason, a 5’ and a 3’ outside probe of 580 
bp and 425 bp, respectively, were generated by PCR. The location of the two probes is 
indicated in figure 12. Both fragments were tested on wild-type (wt) genomic DNA from 
mouse tails.  
 
 
targeted
allele 
wt NR2B
allele 
       = 5’/3’ outside probe 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1
ES cells 
 
Digesti
Souther
 
No hom
Only in
Correct
   
 
4 H N 
H N 
5.6 kb 
2: Screening strategy with rest
positive for homologous recom
on of the genomic DNA
n blot when probed with t
ologous recombination (w
sertion of the neomycin re
 insertion of both loxP siteregion of the targeting constructneo 
8 75 6 H N 
H H N 
9.1 kb 
8.2 kb 
7.7 kb 
riction enzymes Nde I (N) and Hind III (H) for the identification of 
bination. 
 with Hind III should reveal the following bands on a 
he 5’ outside probe (Figure 12): 
ild-type):    8.2 kb 
sistance gene:   9.5 kb 
s and neomycin cassette:  5.6 kb 
 55
Results 
For confirmation of the primary analysis a Nde I digest of the genomic DNA was 
performed. It revealed the following bands on a Southern blot probed with the 3’ outside 
probe (Figure 12): 
 
No homologous recombination (wild-type):   7.7 kb 
Correct insertion by homologous recombination:  9.1 kb 
 
 
             5’ outside probe                                                         3’ outside probe 
 
 
 
 
 
 
 
 
 
C8 C14 
7.7kb
9.1kb5.6 kb 
8.2 kb 
Figure 13: The genomic Southern blots show two putative positive c
fragment sizes when probed with the 5’ and 3’ probes. 
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properties of Cre in mice, however, the removal of the selectable marker used to generate 
the conditional allele is also accomplished by use of Flp recombinase. In order to remove 
the frt-flanked neomycin resistance gene, we used the vector pCAGCGC-FLPe (Schaft et 
al., 2001) for transient expression of the Flp recombinase in mouse ES cells. 15 µg of the 
circular plasmid (pCAGCGC-FLPe) was electroporated into embryonic stem cells from 
the clone C8 in which homologous recombination was successful. 8 days after 
electroporation the clones were grown to the right size for picking. The picked clones 
were distributed in three 96 well master plates containing neomycine resisitant feeder cell 
layers. One of these plates was used for G418 selection in order to differentiate the clones 
lacking the neomycin resistance gene. These clones should not survive the selection. 
After 8 days of selection among the 360 picked clones, 8 candidate clones were found.  
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3.1.4 Generation of the Mouse Line NR2B2lox
 
Among 360 ES cell clones, 6 did not survive the selection procedure and were confirmed 
to lack the neomycin cassette. One of the positive ES cell clones (I8) was injected into 
mouse blastocysts derived from C57Bl6 strain. The blastocysts were implanted in 
pseudopregnant foster mothers, which gave birth to 3 highly chimeric males (F0 
generation). These males were further bred with the C57Bl6 females. In order to prove 
the germline transmission of the mutant allele, 4 weeks after birth a small piece of the tail 
from brown (Agouti) coloured F1 generation litters was taken for DNA preparation and 
analysis by PCR. The F1 offspring from one of the highly chimeric males showed mice 
heterozygous for the mutated allele and wild-type mice in concordance with the 
mendelian rules of 50% probability. As a name NR2B2lox was given to the mouse line. 
 
3.1.5 Genotyping of the NR2B2lox Mice 
 
Genotyping of the mice was performed by PCR using DNA obtained from mouse tails. 
Figure 15 shows the organisation of wild-type and targeted alleles and alignment of the 
PCR primers. Two separate PCRs were used to determine the genotype of each animal. 
Each PCR was designed to amplify over the insertion site of the loxP sites. This resulted 
in PCR fragments of different lengths for the wild-type and NR2B2lox allele. Presence of 
the 3’ loxP site together with the frt site in the absence of the neomycin resistance gene 
was tested by a PCR with the primer pair BD-i6 5’ and BD-i6 3’. The reaction products 
in the wild-type allele and the mutated allele are 213 bp and 328 bp, respectively.  
 
To confirm the presence of the 5´ loxP site and exon 6, PCR with the primers ex 5-5 and 
ex 6-3 was performed. It revealed 641 bp in the wild-type and 690 bp in the mutated 
allele. Southern blot analysis was performed on genomic DNA obtained from mouse liver 
to confirm the correct targeting in mice. For this purpose the same probes were used as 
explained during the screening procedure (Chapter 3.1.2). 
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Figure 16: A) Genotyping strategy by PCR with primer pairs BD-i6 5’, B
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3.2 Confirmation of the NR2B Expression in Mutant Mice 
 
Since the loxP sites are located in introns, they should not in
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3.2.1 Analysis of the mRNA Expression by RT- PCR  
 
Heterozygous mice were used to quantify the mRNA ratio from wild-type versus the 
mutated allele. For this purpose two silent mutations generating an Age I site had been 
introduced into exon 6. RT-PCR (reverse transcription-polymerase chain reaction) is the 
most sensitive technique for mRNA detection and quantification. It was performed on 
RNA from t  brain of adult animals. 
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ers (ex 5.5-2 and ex 8.3) amplify the region covering the silent mutation. The sequencing 
erformed on the 644 bp PCR product using ex 8.3 seq as a primer.  
s were designed to amplify a 644 bp fragment covering the mutation: a sense 
sponding to exon 5 (ex 5.5-2) and an antisense primer corresponding to exon 
The sequencing reaction is performed on the PCR product using internal 
.3seq) (Figure 17). 
ysis, the peaks corresponding to the sequences of the wild-type and the 
le ideally were equal in height in cDNA from heterozygous mice (Figure 18). 
ncing analysis indicated equal level of expression of the mutated allele 
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the Age I site in the NR2B2lox/2lox mice (C and T) in the codons for the amino acids 
thymidine and glycine, respectively. 
 
T C  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: RT-PCR was performed on RNA obtained from animals with three different genotypes (wt, 
NR2B+/2lox, NR2B2lox/2lox) with at least three different animals from each genotype. The figure shows the 
wild-type sequence (top), the sequence with the two silent mutations in homozygous mice (bottom) and the 
overlapping peaks of the equal height (indicating the comparable expression of mutated allele compared to 
wild-type) from the sequence of the heterozygous mice (middle).  
  
3.2.2 NR2B Protein Expression  
 
In homozygous mice with the mutated allele (NR2B2lox/2lox), the expre
NR2B subunit should be same as the expression in the wild-type. In or
equal expression at the protein level, 20 µg of whole brain homogenat
on SDS-PAGE. Western blot analysis was performed on whole brai  wtNR2B+/2loxNR2B2lox/2loxssion level of the 
der to confirm the 
es were separated 
n homogenates of 
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adult (P 60) wild-type and homozygous (NR2B2lox/2lox) mice. The analysis indicated that 
the NR B subunit is expressed at levels comparable to wild-type. 
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 19: Western blot analysis of whole brain homogenates. 
ion of the NR2B subunit in wt and NR2B2lox/2lox mice is comparable. β-actin, a ubiquitously 
ed protein was used as an internal control. 
onditional Ablation of the NR2B Subunit  
he Transgenic Cre4 line and Generation of NR2B∆Fb Mice 
termine the consequences of NR2B subunit deletion in principal cells of the 
ain, we crossed NR2B2lox/2lox mice with the transgenic mice TgCre4 (Mantamadiotis 
2002) to establish the line NR2B∆Fb  (NR2B2lox/2lox/TgCre4). 
ssion of α-CaMKII mRNA starts postnatally in the forebrain (Burgin et al., 1990). 
nal specifity of the 8.5 kb promoter fragment in the TgCre4 of the 
m/calmodulin-dependent protein kinase II-α gene in TgCre4 mice gives the Cre 
binase possibility of a gene knock-out restricted to hippocampal and neocortical 
 known to play central roles in learning and memory. Furthermore, the lack of 
y of the Cre recombinase during prenatal and perinatal periods reduces the 
ility of developmental defects caused by a gene knock-out during early 
pment (Figure 20). 
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Figure 20: Schematic representation of the Cre/loxP recombination by 
TgCre 4 mice. The α-CaMKII promoter fragment guarantees the expr
postnatally only in the principal cells of the forebrain. 
 
3.3.2 NR2B Subunit Expression in NR2B∆Fb Mice 
 
Hippocampal homogenates were prepared from adult (P60-P
and NR2B∆Fb mice. 10 µg of the protein was separated on a
analysis indicated a reduction of the NR2B subunit lev
immunoblot results documented a ∼70% reduction of the NR2
compared to control littermates (NR2B2lox/2lox= 100±20, n= 6 
This way consistent with the electrophysiological studies the
NR2B subunit from the hippocampus is demonstrated. The r
might come from the expression of NR2B in cell populations
most probably in interneurons. loxPcrossing of the NR2B2lox/2lox and 
ession of the Cre recombinase 
120) NR2B2lox/2lox (control) 
 SDS-PAGE. Western blot 
el. Quantification of the 
B subunit in NR2B∆Fb mice 
and NR2B∆Fb= 32±7, n= 6). 
 conditional ablation of the 
emaining ∼30% expression 
 other than pyramidal cells, 
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A previous study had shown that NMDAR activation can have differential effects on 
AMPAR trafficking, depending on subunit composition of NMDARs (Kim et al., 2005). 
It has been suggested that in mature neurons NR2A and NR2B subunits have opposing 
actions on the surface insertion of the GluR-A subunit. The NR2B subunit inhibits the 
insertion whereas the NR2A subunit enhances the insertion. Since overexpression of 
NR2B in culture inhibits the surface expression of GluR-A, I checked if the expression of 
the GluR-A subunit is affected in absence of NR2B in NR2B∆Fb mice at an age between 
P60 and P120. Western blot analysis of hippocampal homogenates did not show a 
significant difference in the expression level of the GluR-A subunit from wild-type 
littermates. Since hippocampal AMPA receptors are mostly heteromers of GluR-A and 
GluR-B, I also checked the possible change in the expression level of the GluR-B 
subunit. The analysis showed no significant difference in the expression profile of GluR-
B between NR2B∆Fb and NR2B2lox/2lox mice. 
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Figure 22: Expression analysis of NR2A, GluR-A and
Hippocampal homogenates from 6 adult mice (P45-P
separated by SDS-PAGE and transferred to nitrocell
antibodies specific for NR2A, GluR-A and GluR-B a
(C), (E). Quantification did not show any change in
subunits in NR2B∆Fb mice compared to NR2B2lox/2lox
experiments of from 6 different animals (B), (D), (F
Student’s t-test (error bars= SD). 
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shows the staining of Cre recombinase in the hippocampal CA1 region (right), and the 
unenhanced EGFP fluorescence (left) from the same section. The expression of Cre 
recombinase together with GFP and the correct targeting of the injected area were proven 
as a control in parallel to the EP studies. 
 
 
 
  
 
 
 
  
 
EGFP Flu
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Th
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e lentiviral expression system was used for in vivo Cre/loxP recombination. 
iral vector for the expression of Cre recombinase and GFP under the control of the α-CaMKII 
 constructed by Valery Grinevich and Pavel Osten. B) Virus particles were delivered 
 to the hippocampal CA1 region of NR2B2lox/2lox mice at P20. GFP mediated fluorescence 
tify and patch clamp cells expected to lack the NR2B subunit. 
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3.4 Electrophysiological Characterisation of the NR2B∆Fb Mice  
 
3.4.1 Increased AMPA/NMDA Ratio and Decreased Ifenprodil Sensitivity 
 
Synaptic EPSCs were evoked by Schaffer collateral stimulation in hippocampal acute 
slices from P 42-45 mice in the presence of 0 mM Mg2+. After recording of total AMPAR 
and NMDAR mediated EPSCs at holding potential of –70 mV from CA1 pyramidal cells, 
5 µM NBQX (AMPA receptor antagonist) was added to the extracellular medium in 
order to isolate NMDAR currents. The NMDA component was then substracted from the 
total synaptic current to calculate AMPAR component. Figure 24 A shows AMPAR 
mediated EPSCs (traces in red) which were normalised and NMDAR mediated EPSC 
(traces in blue). The AMPA/NMDA ratio was increased two fold in the absence of the 
NR2B subunit (NR2B2lox/2lox= 1.73± 0.87, n= 8, NR2B∆lenti= 3.35± 1.35, n= 6 and 
NR2B∆Fb= 3.62± 0.94, n= 3). NMDAR mediated currents were significantly reduced 
assuming that there is no change in the currents mediated by AMPARs. Applicaton of the 
NR2B specific antagonist ifenprodil (10 µM) showed ∼45% reduction of the amplitude of 
the NMDAR mediated synaptic currents in NR2B2lox/2lox mice (54.7± 7, n= 6) whereas it 
did not cause a significant reduction in NR2B∆lenti and NR2B∆Fb mice (92.6± 13.9, n= 5; 
94.5± 10.1, n= 4) (traces in green). Furthermore a decrease in the decay time (from 38.7± 
6.7 ms in NR2B2lox/2lox, n= 11, to 28.1± 6.6 ms in NR2B∆lenti, n= 8, and to 28.7± 5.2 ms in 
NR2B∆Fb, n= 4) could also be seen. NR2B containing receptors have been shown to have 
slower decay times compared to NR2A containing receptors (Monyer et al., 1994; Flint et 
al., 1997). Therefore the faster decay time of the NMDA EPSCs in the mutant can be 
explained by the predominance of NR2A containing receptors. This way it was shown 
that the number of synaptic NMDA receptors is reduced which can be explained by the 
increased AMPA/NMDA ratio. Moreover, lack of sensitivity to ifenprodil and faster 
decay time confirm the absence of synaptic NR2B containing receptors in NR2B∆lenti and 
NR2B∆Fb mice. 
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3.4.2 Reduced NMDAR Component of mEPSCs  
 
Spontaneous vesicular release of glutamate in the absence of action potentials provides 
information about presynaptic release probability (frequency of events) and the number 
of postsynaptic receptors (amplitudes of events).  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
-8
-6
-4
-2
0
50040030020010000 10 20 30 40 50
ms
x1
0-
12
x1
0-
12
0
2
4
6
8
10
12
1
pA
0
0,5
1
1,5
2
1
pA
-0,1
0,1
0,3
0,5
0,7
0,9
1,1
1,3
1,5
1
H
z
peak amplitude of mEPSCs
amplitude of mEPSCs
after 50 ms
frequency of mEPSCs
0
2
4
6
8
10
12
14
16
18
20
1
m
se
c
decay time constant of mEPSCs
*
H
z
m
s
0
0.5
1
1.5
2
pA
-0.1
0.1
0.3
0.5
0.7
0.9
1.1
1.3
1.5
(n= 9)
(n= 12)
(n= 12)
(n= 9)
(n= 9)
(n= 9) (n= 12)
(n= 12)
pA pA
H
z
m
se
cH
z
m
s
NR2B2lox/2lox NR2B∆Fb 
Figure 25: NMDAR component of mEPSCs is strongly reduced. 
mEPSCs in P42-P45 NR2B∆Fb and wild-type mice were recorded at –70 mV in TTX (1 µM), bicuculline 
(10 µM), glycine (10 µM), and low Mg2+ (0.1 mM). In both genotypes, mEPSCs with AMPAR components 
displayed comparable amplitudes, however there was a decrease of the NMDAR component reflected as a 
significant reduction of the amplitude after 50 ms. Data in the graphs are given as mean +/- SD. Differences 
between two groups were evaluated using the unpaired two-tailed Student’s t-test. P values <0.05 were 
considered statistically significant (p<0.05=*; p<0.01=**; p<0.001=***). 
 
Therefore, mEPSCs in P42-P45 NR2B∆Fb and wild-type mice were recorded at –70 mV in 
TTX (1 µM), bicuculline (10 µM), glycine (10 µM), and low Mg2+ (0.1 mM). This 
analysis revealed no significant difference initial peak in amplitude and frequency 
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between both genotypes indicating that there are no changes in the vesicular release and 
number of postsynaptic receptors. This also strongly suggests that the number of AMPA 
receptors in the postsynaptic site is unaltered. Moreover, the decay time constant was not 
significantly changed. AMPA receptors mediate fast synaptic currents and NMDA 
receptors mediate currents that are slower and longer lasting. Therefore the amplitude of 
mEPSCs after 50 ms was assumed as a measure of the NMDAR contribution. The 
reduced amplitude after 50 ms (Figure 25, NR2B2lox/2lox= 1.47± 0.67 pA, n= 9 and 
NR2B∆Fb= 0.67± 0.32 pA, n= 12) gives further evidence for a reduced number of synaptic 
NMDA receptors. 
 
3.4.3 Reduced NMDAR Currents at Somatic Sites  
 
It has been suggested that extrasynaptic NMDARs mainly contain NR2B subunit (Tovar 
and Westbrook, 1999). In order to assess the effect of NR2B ablation, somatic currents 
were recorded in nucleated whole-soma patches from CA1 neurons. Consistent with the 
synaptic recordings the peak amplitude and the decay time of AMPAR currents evoked 
upon application of glutamate did not show any change, indicating that the AMPAR 
component was unaltered (Figure 26 A, B). The observed increase in AMPA/NMDA 
ratio (Figure 26 C, NR2B2lox/2lox= 8.76± 2.36, n= 16, and NR2B∆Fb= 25.58± 6.32, n= 14) 
was attributable to the reduced number of NMDA receptors at extrasynaptic sites as it 
was found at synaptic sites. A significant decrease in the peak amplitude of NMDAR 
currents (Figure 26 D, NR2B2lox/2lox= 308.9± 107.1 pA, n= 16, NR2B∆Fb= 106.5± 36.7 pA, 
n= 16) and decreased ifenprodil (NR2B specific antagonist) sensitivity confirm the lack 
of the NR2B subunit. Moreover, due to lack of NR2B subunits, the kinetics of NMDAR 
currents became faster, which was also reflected by a two fold decrease in the decay time 
(NR2B2lox/2lox= 81.43± 24.43 ms, n= 16, NR2B∆Fb= 37.46± 19.38 ms, n= 17). There was 
no reduction of absolute currents mediated by NMDARs (in NR2B∆Fb mice) after 
ifenprodil application, probably due to unaltered NR2A component (Figure 26 F). A 
puzzling finding was the unchanged decay time (Figure 26 H) after ifenprodil application 
in wild-type mice. The results collected so far were confirmed by experiments in which 
the specific NR2B antagonist CP101,606 was applied instead of ifenprodil (Figure 26 E, 
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F, H). The decay time of the NMDAR currents in wild-type did not change also in the 
presence of CP101,606. This could be due to the contribution of triheteromeric 
NR1/NR2A/NR2B complexes at extrasynaptic sites (Vicini et al., 1998; Tovar and 
Westbrook, 1999) that might have less sensitivity to NR2B antagonists. 
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Figure 26: Nucleated Patches. 
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3.4.4 Impaired Hippocampal Long Term Potentiation  
 
Recent studies propose that activation of NR2A containing receptors solely controls 
induction of LTP (Liu et al., 2004; Massey et al., 2004). This view has been challenged 
by other studies where NR2B subunit contribution was shown to be critical for the 
induction of LTP in hippocampal and anterior cingulate cortex (ACC) (Berberich et al., 
2005; Zhao et al., 2005). The latter are consistent with the results from the transgenic 
mice overexpressing NR2B, which showed enhanced LTP (Tang et al., 1999). NR2A and 
NR2B containing NMDARs coexist in synapses of CA1 pyramidal cells. Their relative 
contribution to synaptic transmission and plasticity is still unclear. 
 
We therefore wanted to determine whether synaptic transmission undergoes LTP in the 
absence of the NR2B subunit. LTP could be induced in hippocampal CA1 pyramidal 
cells from wild-type mice, by pairing Schaffer collateral stimulation with postsynaptic 
depolarisation (depolarisation to 0 mV for 3 min with low frequency presynaptic 
stimulation) under whole-cell conditions. This resulted in a twofold increase of synaptic 
currents (Figure 27 A). To quantify the level of LTP averaged EPSC amplitudes between 
30-40 min after pairing were normalised to baseline (Figure 27 C). In NR2B∆Fb mice 
cellular LTP in hippocampal CA1 pyramidal cells was strongly impaired (NR2B2lox/2lox= 
1.71± 0.2 n= 7, NR2B∆Fb= 1.00± 0.2, n= 6) (Figure 27 B).  
 
The charge transfer during the induction of LTP (calculated from the integral of the 
current over the time) showed a significant decrease in the NR2B∆Fb mice (NR2B2lox/2lox= 
2.70± 1.25 pC, n= 7, NR2B∆Fb= 0.37± 0.30 pC, n= 6). Since the AMPAR mediated 
currents were not altered in the NR2B∆Fb mice compared to NR2B2lox/2lox mice (Chapter 
3.4.2.), the reduction in charge can be attributed to the decreased NMDAR component 
since our previous results from the synaptic and somatic recordings also revealed a 
significant decrease in the peak amplitude of the NMDAR mediated currents and faster 
decay time in the mutant (Chapter 3.4.1, 3.4.3). Ca2+ influx through the NMDA receptors 
is important for the induction of LTP. Therefore we assume that the reduction in charge 
transfer (Figure 27.D) could be related to a decreased Ca2+ influx, and consequently to 
impaired LTP.  
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4 DISCUSSION 
 
4.1 Altering NR2B Allele in Germ Line 
 
4.1.1Embryonic Stem Cells and Removal of the Neomycin Cassette 
 
When a fragment of genomic DNA is introduced into a mammalian cell it can recombine 
with endogenous homologous sequences. This type of homologous recombination has 
been widely used, particularly in mouse embryonic stem (ES) cells to generate so-called 
gene targeted mutations. ES cell lines are probably the most remarkable cell lines ever 
established since they can be cultured and manipulated relatively easily in vitro without 
losing their potential to step right back into their normal developmental programme when 
returned into the early stage embryo. They correspond closely to cells of the inner mass 
of the blastocyst. Even after extended periods of cell culture, ES cell lines can remain 
multipotent and participate in the formation of all tissues, including the gametes. Given 
the possibility of transmitting the altered gene through the germline of a chimeric animal, 
they are frequently used in gene targeting experiments (Robertson et al., 1991). 
Therefore, in the present work mouse ES cells from a clone positive for the homologous 
recombination were injected into mouse blastocysts derived from the strain C57Bl6 to 
generate the NR2B2lox mouse line.  
 
Nearly all constructs used for homologous recombination rely on the positive selection of 
a drug resistance in order to differentiate homologous recombination from random 
integrations. A marker gene, such as the neomycin resistance gene (neo), is routinely 
used to select for targeted ES-cell clones. However, the placement of neo in introns, or in 
5’- or 3’- flanking or untranslated regions, can interfere with the expression of the 
targeted or neighboring genes. In some cases, it has been determined that cryptic splice 
sites in neo interfere with normal splicing and therefore reduce wild-type mRNA levels. 
Therefore it is desirable to flank the neomycin cassette with loxP or frt sites for later 
removal either in vitro in ES cells by transiently introducing a Cre or Flp expressing 
plasmid or by breeding with a mouse line which expresses Cre or Flp in the germ line, 
such that the cassette can be removed. Taking out the neomycin cassette in stem cells 
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increases the passage number of the cells and by this may lead to differentiation of the ES 
cells. Although both approaches were tried in parallel, due to the shorter time span, the 
line NR2B2lox was established from ES cells in which the removal of the cassette was 
performed in culture by using the Flp/Frt system (Schaft et al., 2001). 
 
4.1.2 Conditional Ablation of the NR2B Gene 
 
The ability to inactivate an endogenous gene in the mouse in a temporally and spatially 
controlled manner is not only useful for circumventing early lethal phenotypes but also 
allows biological questions to be addressed with exquisite accuracy. Strategies exploiting 
site specific DNA recombination have been incorporated into transgenic and gene 
targeting procedures to allow in vivo manipulation of DNA in embryonic stem (ES) cells 
(Gu et al., 1993; Orban et al., 1992) or living animals (Lakso et al., 1992; Gu et al., 
1994). In this study we used Cre mediated DNA recombination for conditional ablation 
of the NR2B gene. Success of the experiments depends on the availability of tissue-
specific regulatory elements to drive Cre expression. Nonspecific expression could render 
a Cre transgene useless because of the effective irreversibility of the recombination event. 
Nevertheless, even if the appropriate Cre line is not available, it is an alternative for 
investigators to produce floxed alleles rather than standard ‘knock-outs’. This is because 
they can generate the recombined null allele by using one of the many Cre deleter strains 
and have mice that carry the floxed allele when the right Cre expressing mouse comes 
along in the future. The α-CaMKII promoter in the TgCre4 line guarantees the expression 
of Cre recombinase exclusively in postnatal principal neurons of the forebrain. Since α-
CaMKII is not expressed in inhibitory GABAergic interneurons, this cell population 
lacks Cre recombinase expression in NR2B∆Fb mice. To delete NR2B expression 
specifically in inhibitory neurons, we will use transgenic animals in which Cre 
recombinase is expressed under the control of the parvalbumin promoter or the GAD67 
promoter. These experiments will allow the further investigations of the NR2B 
physiological function in distinct neuronal cell populations.  
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4.2 Lentiviral Expression of Cre Recombinase 
 
Lentivirus vectors based on the human immunodeficiency virus (HIV) represent a 
complex form of retrovirus that can infect and stably transduce dividing as well as 
terminally differentiated cells such as neurons (Naldini et al., 1996). It was also shown 
that a lentiviral vector is able to transduce efficiently and stably in vivo without a 
detectable decrease of transgene expression over time (Blömer et al., 1997). Advantages 
of this system are stable gene expression as well as the lack of immune or cytotoxic 
responses from the host organism. Stereotactic delivery of lentiviral particles to brain 
tissue in vivo allows efficient transduction of populations of neurons in selected brain 
regions, resulting essentially in a creation of local transgenic cells. Moreover, the vector 
system can be modified by including tissue or cell-specific promoters to express genes of 
interest in a subpopulation of cells in the brain. As the particles are pseudotyped with the 
envelope of the vesicular stomotitis virus (VSV), the vector can serve to introduce genes 
into a broad range of tissues and can be used in vivo (Schlegel et al., 1983). Therefore, in 
the present work, a lentiviral vector expressing Cre recombinase and GFP under the 
control of a 1.3 kb α-CaMKII promoter fragment was delivered stereotactically to the 
hippocampal CA1 region of NR2B2lox/2lox mice for the purpose of in vivo Cre/loxP 
recombination. Since the local area of injection limits further behavioural studies, which 
would elucidate the phenotypical consequence of the deletion of the NR2B gene in a 
broader area like the whole forebrain, we also used the TgCre4 line. 
 
4.3 AMPA/NMDA Ratio 
 
In most excitatory synapses AMPA and NMDA receptors coexist together (Bekkers and 
Stevens 1989). Since these receptors have distinct kinetics and the NMDAR is important 
for Ca2+ dependent plasticity (Bliss and Colligridge, 1993; Malenka and Nicoll, 1999), 
the ratio of NMDAR to AMPAR mediated currents is likely to be a key determinant of 
both short-term integration of synaptic inputs and their long-term modification.  
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We wanted to demonstrate NR2B ablation and its effects in the hippocampus by using a 
combination of biochemical and electrophysiological studies. Western blot analysis of 
hippocampal homogenates of NR2B∆Fb mice showed a reduction of NR2B subunit 
expression by 70%. Synaptic recordings from CA1 pyramidal cells revealed a twofold 
increase in the AMPA/NMDA ratio in NR2B∆Fb mice, which is probably due to the 
decreased amplitude of the current mediated by NMDARs. To exclude that the currents 
mediated by AMPARs were responsible for the increased AMPA/NMDA ratio, mEPSCs 
were recorded. Since the mEPSCs showed no significant difference in initial peak 
amplitude and frequency between NR2B2lox/2lox and NR2B∆Fb the number of AMPA 
receptors in the postsynaptic site in mutant mice appeared to be unaltered. Furthermore, 
the data from the western blot analysis of the hippocampal homogenates revealed 
comparable expression of GluR-A and GluR-B between the two genotypes. On the other 
hand a previous study (Kim et al., 2004) reported that in mature neurons NR2A and 
NR2B subunits have opposing actions on the surface insertion of the GluR-A subunit 
with NR2B subunit inhibiting its insertion. They found that overexpression of NR2B in 
culture inhibits the surface expression of GluR-A. Our results from the western blots of 
the hippocampal homogenates strongly suggest that in the absence of NR2B, there is no 
significant difference in the expression level of the GluR-A subunit , however, we did not 
check specifically the surface expression of the GluR-A. It is known that AMPA 
receptors mediate fast synaptic currents and NMDA receptors mediate currents that are 
slower and longer lasting (Dingledine et al., 1999). In line with this we viewed the 
reduced amplitude of mEPSCs after 50 ms as a measure for the reduced NMDAR 
contribution. By this way, in the present study we propose that the increased 
AMPA/NMDA ratio in NR2B∆Fb mice is solely due to the reduction in the number of 
NMDA receptors.  
 
4.4 Kinetic Properties 
 
During postnatal development, the duration of currents mediated by NMDA receptors 
decreases. Primary neuronal cultures expressing NR2A subunit mRNA had faster 
NMDAR EPSCs than cells with no expression of this subunit (Flint et al., 1997). 
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Increasing the contribution of NR2A-containing receptors to the synaptic current 
decreases the contribution from the NR2B subunit. The gradual supplementation of 
NR2B by NR2A during postnatal development has been implicated in the speeding of the 
decay of synaptic NMDAR mediated currents (Monyer et al., 1994; Flint et al., 1997; 
Cull-Candy et al., 2001). In vitro, NR2B containing receptors have slower decay times 
compared to NR2A containing receptors (Monyer et al., 1994; Cull-Candy et al., 2001). 
In accordance with this, our results from synaptic recordings of CA1 pyramidal cells 
lacking the NR2B subunit showed a dramatic reduction in the decay time (see results). 
Our findings are in line with a study which reported that NMDAR mediated EPSCs from 
cultured hippocampal neurons lacking the NR2B subunit have very fast deactivation 
kinetics compared to those from wild-type neurons (Tovar et al., 2000). Moreover, our 
finding is consistent with data from genetically modified mice overexpressing the NR2B 
subunit, which revealed 1.8 fold slower decay of NMDAR mediated currents in mature 
neurons (Tang et al., 1999). Application of the NR2B specific antagonist ifenprodil (10 
µM) did not show a significant reduction in the currents mediated by NMDARs in CA1 
pyramidal cells lacking NR2B. Lack of sensitivity to ifenprodil and faster decay time 
confirmed the absence of synaptic NR2B containing receptors in NR2B∆lenti and NR2B∆Fb 
mice. Additionally, western blot analysis of hippocampal homogenates also showed a 
comparable NR2A subunit expression in mutant and wild-type mice. Therefore, the faster 
decay time of the NMDAR mediated EPSCs in absence of NR2B can be explained by the 
predominance of NR2A containing receptors.  
 
4.5 Cellular Plasticity 
 
Both NR2A- and NR2B-type NMDA receptors activate signalling pathways that lead to 
LTP formation (Köhr et al., 2003). The NR2B subunit predominates early in development 
whereas expression of NR2A starts shortly after birth and gradually increases to the adult 
levels (Monyer et al., 1994). Increasing incorporation of NR2A subunits could underlie 
some of the changes in NMDA receptor properties observed during postnatal 
development. It has been hypothesized that a developmental switch from NR2B to NR2A 
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at synaptic sites may be responsible for the decreased plasticity observed in older animals 
(Carmignoto and Vicini, 1992; Crair and Malenka, 1995).  
In young animals, both NR2A and NR2B contribute to LTP, whereas in adult animals, 
NR2A mediated signalling dominates (Köhr et al., 2003). Interestingly, studies of 
transgenic mice overexpressing NR2B in the adult forebrain demonstrate the important 
contribution made by NR2B subunits to hippocampal LTP (Tang et al., 1999) and 
behavioural learning (Tang et al., 1999; Wong et al., 2002). These mice exhibit enhanced 
LTP and a superior ability in learning and memory in various behavioural tasks. 
However, the authors did not try to prove that the beneficial effects of the transgenic 
overexpression of NR2B are not simply due to the higher number of total NMDA 
receptors and not specific for the NR2B subunit. A possible control would have been 
transgenic overexpression of NR2A. Whereas mice with targeted disruption of the NR2A 
subunit have reduced LTP and deficiencies in certain learning tests (Sakimura et al., 
1995), mice lacking a functional NR2B gene die at birth (Kutsuwada et al., 1996). It is 
likely that both NR2A and NR2B dependent pathways are involved in memory formation 
in adult mice because, in contrast to mice that lack all NMDARs in CA1 pyramidal cells 
(McHugh et al., 1996), NR2A knock-out mice are less impaired in learning tests (Kiyama 
et al., 1998), and activation of NR2B-type NMDARs restores LTP in mice with absent or 
impaired NR2A signalling (Kiyama et al., 1998; Köhr et al., 2003) Alternatives to NR2 
knock-out mice are gene-manipulated mice which express C-terminally truncated NR2 
subunits. Mice in which the C-terminal domains of NR2 subunits are truncated show the 
same phenotype as the knock-out of the corresponding NR2 subunit with the NR2B 
showing the most severe phenotype (Sprengel et al., 1998; Mori et al., 1998). Most of 
these mice express gateable receptors that are synaptically activated, but are defective in 
intracellular signalling and less prominent in synaptic localisation. A recent study reports 
that hippocampal LTP is mediated by NMDARs containing the NR2A but not the NR2B 
subunit (Liu et al., 2004). This finding suggests that the NR2B receptors in the 
hippocampus may not contribute to learning-related synaptic potentiation, however, no 
behavioural study has demonstrated the inhibitory effect that NR2B antagonists may have 
on learning when injected locally in the hippocampus. Although yet another study also 
claims that activation of NR2A containing receptors solely controls induction of LTP 
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(Massey et al., 2004), this view has been challenged by other studies which reported the 
important contribution of NR2B for LTP induction (Berberich et al., 2005; Zhao et al., 
2005). NR2A and NR2B subunits predominate in the forebrain, but their relative 
contribution to synaptic transmission and plasticity is still a challenge and not clearly 
understood. 
 
To expand the knowledge in this field we examined if synaptic transmission undergoes 
LTP in the absence of the NR2B subunit. Our results demonstrated that cellular LTP in 
hippocampal CA1 pyramidal cells was strongly impaired in the absence of the NR2B 
subunit. Our finding is consistent with those results on genetically modified mice, in 
which NR2B expression was upregulated (Tang et al., 1999; Wong et al., 2002;) or NR2A 
signalling was impaired (Kiyama et al., 1998; Köhr et al., 2003). In summary, our results 
do not support the model that only NR2A-type NMDARs are responsible for LTP 
induction (Collingridge et al., 2004; Liu et al., 2004; Massey et al., 2004). It was reported 
in a CA3 specific knock out of the NR2B subunit that LTP could not be induced. 
However in contrast to our western blot analysis NR2A protein expression was 
drastically reduced, and NMDAR responses were hardly detected the CA3 synapses 
(Toshikazu et al., 2004 SFN Abstract). On the other hand, one can still argue and propose 
with our findings that the impaired LTP can be due to the decreased number of NMDA 
receptors rather than absence of the NR2B subunit. In order to elucidate if the impaired 
LTP is due to the lack of signalling cascades triggered specifically by the NR2B subunit, 
detailed investigation can be performed via overexpression of the NR2A in the absence of 
NR2B and further analysis of cellular LTP. One way to achieve this can be the 
stereotactic delivery of lentiviral particles co-expressing NR2A and GFP to the CA1 
region of NR2B∆Fb mice. This way we want to find out if NR2A overexpression can 
rescue the impaired cellular plasticity in the absence of the NR2B subunit by increasing 
the total number of NMDA receptors. Whole-cell LTP can be induced by different 
stimulation paradigms, such as HFS (high frequency stimulation), pairing of action 
potentials with EPSPs with appropriate timing or pairing of postsynaptic depolarisation 
with low frequency stimulation (the protocol which was used in this study). Moreover, 
with another method the increase in synaptic transmission from a population of CA1 
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neurons can be recorded (field LTP). Our future electrophysiological studies will include 
LTP induction experiments by application of different protocols. 
 
4.6 Somatic NMDAR Currents 
 
NR2A subunits are incorporated synaptically late in development, whereas NR2B 
subunits are still highly persistent at extrasynaptic sites (Stocca and Vicini, 1998; 
Rumbaugh and Vicini, 1999; Tovar and Westbrook, 1999). In order to explore this view 
somatic currents were recorded in nucleated whole-soma patches from CA1 neurons in 
the absence of the NR2B subunit. In accordance with our results from the synaptic 
recordings the data showed that the AMPAR component was not changed in mutant 
mice. Therefore the observed increase in the AMPA/NMDA ratio could be due to the 
reduced number of NMDA receptors at extrasynaptic sites as it was found at synaptic 
sites. Lack of NR2B subunit was verified by reduced peak amplitudes of the NMDAR 
mediated currents and lack of sensitivity to NR2B antagonists at somatic sites. In 
conformity with synaptic recordings, the kinetics of NMDAR currents became faster. It 
has been suggested that some native NMDAR channels contain more than one type of 
NR2 subunit in the same assembly (Dunah et al., 1998; Sheng et al., 1994; Luo et al., 
1997). Although studies in a heterologous system report the formation of functional 
triheteromeric assemblies of NR1/NR2A/NR2B (Vicini et al., 1998; Tovar and 
Westbrook, 1999), it is still unknown to what extent these assemblies are formed in vivo. 
Our rather surprising finding of the unchanged decay time after NR2B antagonist 
application (ifenprodil and CP101,606) in wild-type mice could be explained by the 
possible contribution of these triheteromeric NR1/NR2A/NR2B complexes at 
extrasynaptic sites, which might be less sensitive to these antagonists (Vicini et al., 1998; 
Tovar and Westbrook 1999).  
 
4.7 Future Perspectives 
 
We believe that the conditional knock-out of the NR2B gene will bring new insight into 
the field by elucidating the specific function of NR2B in learning and memory which is 
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still enigmatic. We observed that NR2B∆Fb mice grow and mate normally compared to 
wild-type littermates. Since the overexpression or upregulation of the NR2B subunit 
showed superior ability in learning and memory in the behavioural tests (Tang et al., 
1999; Wong et al., 2002), whereas the global knock-out of the NR2B was lethal 
(Kutsuwada et al., 1996) we want to explore the effect of the NR2B ablation on learning 
and memory by performing specific behavioural studies, as for example novel object 
recognition, contextual, cued fear conditioning, and spatial reference, working memory 
by water maze and T maze. 
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5 ABBREVIATIONS 
 
α   alpha 
α32P-dCTP  deoxicytosin triphosphate labelled with 32P in alpha position 
A   amphere 
D-AP5   D-5-amnino phosphonate pentanic acid 
ATP   adenosine triphosphate 
AAV   adeno-associated virus 
BIP   bovine immunodeficiency virus 
BAPTA  1,2-bis-(2-aminophenoxy)ethane-N,N,N,N,N- tetracetic acid 
BDNF   brain-derived neurotropic factor 
bp   baise pairs 
C   Celsius 
CA   cornu ammonis 
CaMKII  Ca2+/calmodulin-dependent proteinkinase II 
CMV   cytomegalovirus 
CNS   central nervous system 
CNQX   6-Cyano-7-nitroquinoxaline-2,3-dione, Ampa antagonist 
cDNA   complementary DNA, obtained by reverse transcription of        
                                    mRNA 
∆   delta 
DEPC   diethyl pyrocarbonate 
DNA   deoxyribonucleic acid 
dNTPs   deoxyribonucleotides  
E.coli   ecsherichia coli 
EDTA   ethylene diaminetetraacetic acid 
EGTA   ethylene glycol-bis(2-aminoethyl)-N,N,N,N-tetraacetic acid 
EGFP   enhanced green fluoroscent protein 
EPSC   excitatory postsynaptic current 
EPSP   excitatory postsynaptic potential  
ES cells  embryonic stem cells 
et al.   et alii 
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FIV   feline immunodeficiency virus 
G-protein  guanosine nucleotide-binding protein 
GABA   γ-aminobutiric acid 
γ   gamma 
GluR   glutamate receptor      
G418   Genetecin 
GTP   guanosine triphosphate 
h   hour 
HEPES  N-(2-Hydroxyethyl)piperazine-N`-ethanesulforinic acid 
HSV   herpes simplex virus 
IPSP   inhibitory postsynaptic current 
IRES   internal ribosomal entry site from the encephalomyelitis virus  
   gene 
IC50   concentration required for half maximal response 
KA   kainite 
kb   kilobase 
kD   kilodalton 
K.O   knock-out gene 
LTD   long term depression 
LTP   long term potentiation 
LTR   long terminal repeats 
M   mol 
m   milli 
µ   micro 
mEPSC  miniature evoked postsynaptic current 
MMLV  Moloney Murine Leukaemia Virus 
N   asparagine 
neo   neomycin resistance gene 
NMDA  N-methyl-D-aspartate 
NMDAR  N-methyl-D-aspartate receptor 
NO   nitric oxide 
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NOS   nitric oxide synthase 
NR1   NMDAR subunit 1 
NR2   NMDAR subunit 2 
NR3   NMDAR subunit 3 
NBQX   1,2,3,4-Tetrahydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7-
sulfoamide 
Neo   neomycin resistance gene 
NVP-AAM077 (1RS,1’S)-PEAQX, NR2A subunit specific antagonist 
p   pico 
P   postnatal 
p   probability 
PBS   phosphate-buffered saline 
PCR   polymerase chain reaction 
PDZ domain  post synaptic density/disc large/zona ocludens-1 homology  
                                    domain 
PFA   paraformaldehyde 
PKA   cyclic AMP-dependent protein kinase A 
PKC   protein kinase C 
PSD   postsynaptic densitiy 
Q   glutamine 
R   arginine 
RNA   ribonucleic acid 
RT-PCR  reverse transcription coupled to ploymerase chain reaction 
s   second 
SDS   sodium-dudecyl-sulfat 
SDS-PAGE  SDS-PloyAcrylamide Gel Electrophoresis 
STEDV  standart deviation 
Taq   therminus aquaticus 
TE   tris/EDTA buffer 
TENS   tris-EDTA_Sodium chloride-SDS buffer 
Tris-HCl  Tris(hydroxymethyl)aminomethane-hydrochloride 
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TTX   tetrodoxin 
U   units 
WRE   woodchuck regulatory element 
Wt   wild-type 
VSV-G  vesicular stomatitis virus glycoprotein 
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